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1Introduction
1.1 Motivation
Cells process input signals to output signals using a network of cellular signalling path-
ways (Berg et al. (2012)). For example, a small molecule binds a membrane receptor.
The signal is brought into the cell via structural modification of the receptor. A set of
kinases and other signalling molecules propagate the signal through the cytosol. This
involves both activation and repression of proteins. Often complexes of multiple proteins
must form before a signal propagates. Eventually, the signal enters the nucleus and tran-
scription factors become activated. Finally, the combination of activated transcription
factors and regulatory co-factors leads to the transcription of a large set of genes. Even-
tually, this can lead to changes of the cell phenotype. Some of the involved molecules
are also part of other pathways linking multiple pathways together. Understanding the
structure and the interplay of pathways is crucial both for understanding the cellular
mechanism and for designing novel therapies that target specific pathways.
Inferring networks from molecular profiles is a well developed field in bioinformatics.
Transcriptional data can be generated more easily compared to protein activation data.
Consequently, many algorithms were developed that focus on the reconstruction of reg-
ulatory networks, for example Gaussian graphical models (GGM) (Schäfer & Strimmer
(2005)), Bayesian networks (Friedman et al. (2000)) or the PC-algorithm (Kalisch &
Bühlmann (2007)), the Algorithm for the Reconstruction of Accurate Cellular Networks
(ARACNE, Margolin et al. (2006)). All these methods use observational gene expres-
sion data to construct regulatory networks based on diﬀerent association scores between
genes.
It is no problem to quantify the expression of any gene using standard methods like
qPCR, microarrays, or RNAseq (Chang (1983); Schena et al. (1995); Lashkari et al.
(1997); Mortazavi et al. (2008); Morin et al. (2008); Chu & Corey (2012); Logan
et al. (2009)). Observing signalling networks is more complicated. Protein activation
can operate on the levels of protein expression, cellular protein localization, and protein
modifications like phosphorylation, ubiquitination etc. While there are assays to assess
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activation on any of these levels, those assays are more elaborate, more expensive and less
generic. Moreover, for every protein we need to know a priori which type of modification
mediates signal transduction.
Biologists have been inferring pathways without formal computations for many years.
In this classical approach functional/interventional data is used. Pathways are perturbed
by knock-out, knock-down or knock-ins of genes. The consequences of the interven-
tions are observed and interpreted. Markowetz et al. (2005) summarize this strategy by
“What I cannot break, I cannot understand”. Complementing the biology tradition, there
are several computational approaches that exploit intervention data. Markowetz et al.
(2005) introduced Nested Eﬀects Models (NEM) (Markowetz et al. (2007); Froehlich
et al. (2011); Niederberger et al. (2012)). This method was designed to infer non-
transcriptional signalling pathways by transcriptional downstream eﬀects of pathway per-
turbation. A pathway is activated in a set of cellular assays where specific pathway genes
are silenced. The silencing blocks branches of the pathway. Genes that normally change
expression in response to the stimulus no longer react in knock-down assays. Typically
the eﬀected gene sets diﬀer from silenced gene to gene. NEMs infer the network structure
from the nesting of these sets. In a nutshell: if the eﬀected genes of perturbing gene B
are a noisy subset of the eﬀected genes of gene A, then A is upstream of B. This concept
has been extended to time series data (Anchang et al. (2009); Froehlich et al. (2011);
Dümcke et al. (2014)), evolving networks (Wang et al. (2014)) and network inference
with hidden confounders (Sadeh et al. (2013)).
To date NEMs can infer the upstream/downstream relations of genes in a pathway
(Markowetz et al. (2005)), they can distinguish activation from repression (Vaske et al.
(2009)) and they can resolve the flow of information (Anchang et al. (2009); Froehlich
et al. (2011)). However they cannot model the role of complex formation in signalling
pathways. If a protein X is activated by a complex, all members of the complex must
be present and in the correct activation state. The proteins in the complex operate
concertedly and are linked to X by an AND gate. In another scenario, X can be activated
independently by several proteins. In this case the proteins operate non-synergistically
and an OR gate links them to X.
Boolean Networks (Kauﬀman (1969), Gershenson (2004)) can distinguish logical gates.
They have been used to simulate signalling pathways (Klamt et al. (2006, 2007)) and to
reconstruct them from interventional data (Saez-Rodriguez et al. (2009)). Its assumed,
that the data is produced by an unknown Boolean network, a ground truth network
(GTN). Methods for reconstruction aim to infer a network from the data as close to
the unknown GTN as possible. Boolean networks impair this goal, because allowing
logical gates leads to identifiability problems of network structures (figure 4.6). Especially
considering “incomplete” experimental designs. For example if only single knock-down
assays are available and the GTN has A go into B and C, while B and C can activate D
independently of each other, the GTN is equivalent to the one which has A go into B,C
and D directly. To overcome this limitation, prior knowledge on the pathway structures
is used. Saez-Rodriguez et al. (2009) describe an algorithm called CellNet Optimizer
(CNO) to construct signalling pathways from molecular data in the Boolean Network
framework. They combine prior knowledge networks, with protein phosphorylation data
form interventional assays.
In the future experimental approaches will become more refined and exact. Not only
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single perturbations, but double, triple, and so on will become standard. Furthermore
noise and unwanted eﬀects from the perturbations will become less prominent. Com-
binatorial perturbations have already been used to resolve biological network structures
Bonneau et al. (2006); Nelander et al. (2008). This way the use of literature knowledge
can be reduced and the complex Boolean structures of the pathways can be reconstructed
from scratch.
Here we describe Boolean Nested Eﬀect Models (B-NEM). This method combines
advantages from Boolean Network Models and Nested Eﬀect Models. Like Boolean Net-
works they can distinguish between the synergistic and non-synergistic activation of a
protein, and like in Nested Eﬀect Models we do not need direct observations of protein
activity. Moreover, B-NEMs can use data from assays, where several pathway genes are
perturbed simultaneously. Contrary to the original NEM , B-NEM does not discriminate
between stimulation (knock-in) or inhibition (knock-out) of a protein except for the as-
signed value. Thus the same protein can be overexpressed or stimulated in one (1) and
inhibited (0) in another experiment.
1.2 Organization
First, in section 1.3 we will give a short overview of the biological processes of a cell.
We explain, why it is important, that these processes remain undisturbed in healthy
organisms. We also describe the kind of data we use with our method. The next chap-
ter reviews the Boolean algebra and (hyper-)graph theory, which build the bases of the
mathematical concept. In chapter 3 we will give an overview of established methods in
the field of network reconstruction from biological data. In chapter 4 we give a detailed
description of our novel method (B-NEM) to make inference of protein signalling path-
ways based on secondary eﬀects from perturbation experiments. We validate B-NEM
on simulated data in chapter 5. In chapter 6 we elucidate, how Pi3k and Tak1 mediate
B-Cell receptor signalling into the Jnk, p38 and Ikk2 pathways in lymphoma cells. In
chapter 7 we apply B-NEM to a dataset derived from hepatocellular carcinoma cells and
investigate the crosstalk between apoptotic (Trail) and inflammatory (Tnf-) signalling.
In the last chapter 8 before the conclusion, we use B-NEM to discover cyclic signalling
in developmental phases of mouse embryonic stem cells.
If not stated otherwise, all Graphs in this work have been created with the help of
the Rgraphviz package (Hansen et al. (n.d.)). The R scripts for B-NEM are available at
https://github.com/MartinFXP/B-NEM.
1.3 Intracellular Signalling Pathways in the Context of
Cancer
Protein Signalling Pathways
A protein signalling network or pathway is a set of proteins, which interact inside a cell.
These interactions can happen in diﬀerent ways. For example protein A can change
the activity of protein B by processes such as phosphorylation, de-phosphorylation or
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ubiquitination. Or two proteins form a complex and together interact with other proteins
to propagate a signal.
A pathway is usually stimulated when a protein from outside the cell attaches to a
protein in the cell membrane (receptor). For instance the tumor necrosis factor  (Tnf)
binds to the Tnf receptor 1 (Tnfr1). The receptor changes its shape inside the cell.
Intracellular proteins such as Traf2 and Rip1 bind to the receptor and become active.
They propagate the Tnf- signal via other proteins such as signalling kinases (e.g. Mekk,
Nik, Tak1). At the end of the pathway members of the NfB protein family (e.g. RelA,
RelB) become active and transcribe genes responsible for an inflammatory response which
promotes cell survival (Wajant et al. (2003); Bradley (2008); Haas et al. (2009); Silke
(2011); Metzig et al. (2011a); Walczak (2011); Darding & Meier (2012); de Almagro &
Vucic (2012)).
Signalling in Cancer
Random mutations are regularly introduced into the genome. Most mutations do not
alter function and behaviour of a cell. However, sometimes a mutations occurs at a vital
part of the genome, like a gene, which can lead to abnormal behaviour of the cell (Kan
et al. (2013); Tornesello et al. (2013)). For example NfB is constitutively active in
some cases of liver cancer, which entails tumor growth (Dufour & Clavien (2005)).
Several processes can cause mutated DNA. For example UV light or radiation directly
damages the DNA of the genome. If that happens, automatic repair mechanisms will
try to reverse this damage. These mechanisms are stochastic processes and can fail to
correctly repair the aﬀected area of DNA. In other words mutations occur in that part
of the genome. Another process that can lead to mutations is the division of one cell
into two identical daughter cells. Before the cell splits in two, it grows and duplicates
its genome. If this duplication is imperfect one or both of the daughter cells become
mutated. In general any process involving building or processing the genome entails the
danger of mutated cells and tumor development.
Mutations can alter the behaviour of signalling pathways. Every signalling pathway
has certain tasks such as the induction of programmed cell death (apoptosis, Brune
Bernhard (2003)). If a mutation disturbs such a pathway, the cell won’t work properly
anymore. For example if cells are damaged beyond repair, normally they will undergo
apoptosis and die. The apoptotic signal is propagated via caspase 9 to eﬀector caspases
3 and 7. The eﬀector caspases degrade proteins in the cell, which leads to cell death.
However, a mutation in one or both eﬀector caspases 3 and 7 might prevent programmed
cell death and promote cancer development (Soung Young Hwa et al. (2003); Soung et al.
(2004)).
Perturbation Biology
We infer the properties of signalling pathways with the help of perturbation experiments.
Perturbing a pathway can be done in diﬀerent ways. Usually a stimulation induces the
pathway and it becomes active (Shapiro & Vallee (1991); Boutros et al. (2002)). The
active pathway propagates the signal. Additionally to the stimulation we can inhibit
a member of the pathway. Then we observe the phenotype of a cell type for diﬀerent
combinations of stimulations and inhibitions (Hamilton & Baulcombe (1999); Agrawal
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et al. (2003); Boutros et al. (2004, 2006); Boutros & Ahringer (2008)). A cell phenotype
is an observation of the cells state such as mRNA abundances (Chang (1983); Schena
et al. (1995); Lashkari et al. (1997); Mortazavi et al. (2008); Morin et al. (2008); Chu
& Corey (2012)) or cellular dynamics (live cell imaging, Monya (2010)).
Gene Expression Profiles
We want to make inference on the signalling pathway of a cell by looking at its phenotype
after a series of experiments: stimulation of a receptor, knock-down of a gene, inhibition
of a protein. In our case the phenotype of a cell in a specific experiment is defined by
gene expression profiles. For each experiment and each gene we look at the gene’s mRNA
abundance (expression). The gene expression of one gene over a series of experiments is
the gene expression profile of this specific gene, while the expression of all genes in one
experiment is the global gene expression profile of this experiment. Several technologies
exist to measure gene expression such as the microarray technology (Chang (1983); Schena
et al. (1995); Lashkari et al. (1997)) or RNAseq (Mortazavi et al. (2008); Morin et al.
(2008); Chu & Corey (2012)).
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2Boolean Hyper-Graphs
2.1 Boolean Algebra
This chapter reviews Boolean algebra (Mendelson (1970); Rosen (2012)), (hyper-)graph
theory and Boolean signalling graphs as described in Klamt et al. (2006, 2007) and
Saez-Rodriguez et al. (2009, 2011).
Definition 2.1 (Boolean function). A function f is Boolean, if it takes a set of n inputs
with binary values and returns one binary output.
f : f0; 1gn ! f0; 1g :
We write Boolean functions as normal forms. The input variables x1; : : : ; xn 2 f0; 1g
are called literals. ^ denotes the AND operator.
x ^ y = 1 if and only if x = 1 and y = 1:
_ denotes the OR operator.
x _ y = 0 if and only if x = 0 or y = 0:
The negation operator : works as follows.
:x = 1 if and only if x = 0:
Literals can be combined by the AND operator in what we call a clause:
(x1 ^ : : : ^ xm) = 1 if and only if xk = 1 for all k:
These kind of clauses can then be combined by the OR operator. We call combination
normal form. _
j
(xj1 ^ : : : ^ xjm) = 1 if and only if
there exists at least one j for which xjk = 1 holds for all k:
(2.1)
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In other words, a normal form as in (2.1) is 1 if there is at least one clause, in which every
literal is 1 and 0 otherwise. The number of literals in each clause can vary. A normal
form as in (2.1) is called disjunctive (DNF). Alternatively we define a conjunctive normal
form (CNF): ^
j
(xj1 _ : : : _ xjm) = 1 if and only if
for each j there exists at least one k for which holds xjk = 1:
(2.2)
In other words a CNF is 1, if in each clause there is at least one literal, which is 1. It is
0 otherwise.
There are several rules to convert normal forms.
Identities:
x ^ 1 = x (2.3)
x _ 0 = x (2.4)
Commutativity:
x ^ y = y ^ x (2.5)
x _ y = y _ x (2.6)
Associativity:
x ^ (y ^ z) = (x ^ y) ^ z (2.7)
x _ (y _ z) = (x _ y) _ z (2.8)
Double negation:
:(:x) = x (2.9)
De Morgan Laws:
:(x ^ y) = :x _ :y (2.10)
:(x _ y) = :x ^ :y (2.11)
Idempotencies:
x ^ x = x (2.12)
x _ x = x (2.13)
Annihilators:
x ^ 0 = 0 (2.14)
x _ 1 = 1 (2.15)
Distributivity Laws:
(x ^ y) _ z = (x _ z) ^ (y _ z) (2.16)
(x _ y) ^ z = (x ^ z) _ (y ^ z) (2.17)
Absorption:
(x ^ y) _ x = x (2.18)
(x _ y) ^ y = y (2.19)
Complementation:
x ^ :x = 0 (2.20)
x _ :x = 1 (2.21)
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Every DNF can be converted into a CNF and vice versa. This is done by applying the
distributivity laws in (2.16)-(2.17). After we have applied the distributivity laws other
rules are helpful to reduce the normal form. For example:
(:x ^ :y) _ (z ^ x ^ :y)
(2.16)z}|{
= (:x _ z) ^ (:x _ x) ^ (:x _ :y) ^ (:y _ z) ^ (:y _ x) ^ (:y _ :y)
(2.21)z}|{
= (:x _ z) ^ 1 ^ (:x _ :y) ^ (:y _ z) ^ (:y _ x) ^ (:y _ :y)
(2.13)z}|{
= (:x _ z) ^ 1 ^ (:x _ :y) ^ (:y _ z) ^ (:y _ x) ^ :y
(2.3)z}|{
= (:x _ z) ^ (:x _ :y) ^ (:y _ z) ^ (:y _ x) ^ :y
(2.19)z}|{
= (:x _ z) ^ :y:
(2.22)
We define the dual form of a normal form by switching ^ and _ operators. The dual
form includes the dual literals, which have inverse values. The dual literals are marked
with a . For example the dual form of the initial form in (2.22) is
(:x _ :y) ^ (z _ x _ :y): (2.23)
For the dual literals it holds that, if x = 1, then x = 0 and vice versa.
Remark 2.1 (Property of the dual form). Let X = fxigi2IN be a set of literals, N a
normal form and N its dual form.
If (xi = 1 8i 2 J  I ) N = 1), then (xi = 0 8i 2 J  I ) N = 0).
Proof. Let N =
V
j
(xj1 _ : : : _ xjm) be a CNF. If N = 1, then for each j there exists at
least one k for which xjk = 1. N =
W
j
(xj1 ^ : : : ^ xjm) is the dual form of N . If the dual
of literals from before are 0 (xjk = 0), every clause in N
 is 0 and therefore N is 0.
Let N =
W
j
(xj1 ^ : : : ^ xjm) be a DNF. If N = 1, there exists at least one clause j for
which we have xjk = 1 for all k. N =
V
j
(xj1 _ : : : _ xjm) is the dual form of N . If the
dual of literals from before are 0 (xjk = 0), there is one clause j, which is 0. Thus N
 is
0.
For instance if x; z;:y are all 1, then (:x ^ :y) _ (z ^ x ^ :y) is 1. If x; z;:y are
all 0, then (:x _ :y) ^ (z _ x _ :y) is 0.
2.2 Graphs and Hyper-Graphs
In this chapter we review (hyper-)graph theory (Wilson (1996),Bretto (2013)).
Definition 2.2 (graph). A set G = (V;E) of vertices v 2 V and edges E = fe = fv; wg ; v; w 2 V g
is a graph.
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Definition 2.3 (walk). A subset fv1; : : : ; vng  V is a walk, if for all pairs vi; vi+1 exists
an edge e 2 E with the property e = fvi; vi+1g.
Definition 2.4 (path). A walk fv1; : : : ; vng is a path, if (vi 6= vj , i 6= j).
Definition 2.5 (cycle). A walk fv1; : : : ; vng is a cycle, if v1 = vn.
Figure 2.1 shows a graph with several walks, paths and cycles. There are for example
the walks fS0; S1; S2; S3; S4; S1g and fS0; S1; S2; S3; S4; S5g, the paths fS1; S2g and
fS2; S3g, and the cycles fS1; S2; S3; S4; S1g and fS4; S1; S2; S3; S4g. The second walk
is also a path.
Definition 2.6 (subgraph). G = (V;E) is a subgraph of a graph G = (V ; E) if V  V 
and E  E.
Definition 2.7 (directed graph). A graph G = (V;A) is directed with arcs a = (v; w) 2 A,
if (v; w) denotes a directed relationship between v and w. Vertex v is the parent of a and
w the child. Not that in a directed graph the edge (v; w) is diﬀerent to the edge (w; v).
Definition 2.8 (connectedness). A directed graph G is connected, if for two vertices
v; w 2 V there is either a path fv; : : : ; wg or a path fw; : : : ; vg.
Definition 2.9 (directed acyclic graph (DAG)). A directed graph G = (V;A) is acyclic,
if it contains no cycles.
S0
S1
S2
S3
S4
S5
Figure 2.1: Graph with cy-
cle. A graph containing the cycle
fS1; S2; S3; S4; S1g (green). It has
one additional incoming and one
outgoing edge.
Hyper-graphs generalize normal graphs (Bretto
(2013)). Contrary to normal graphs hyper-graphs
allow us to depict associations between more than
just two vertices. Thus a normal graph is a hyper-
graph with edges including exactly two vertices.
Definition 2.10 (hyper-graph). A set H = (V;E)
of elements (vertices) v 2 V and (edges) E =
fe = (W1;W2) ;W1;W2  V g is a hyper-graph.
In the rest of this thesis we only use directed
hyper-graphs with cardinality jW2j = 1.
Definition 2.11 (walk). A subset fv1; : : : ; vng  V
is a walk, if for all pairs vi; vi+1 exists a hyper-edge
e 2 E with e = (W; vi+1) ; vi 2 W .
Definition 2.12 (directed hyper-graph). A hyper-
graph G = (V;A) is directed with arcs (W; v) 2 A,
if (W; v) denotes an order between the sets W and
fvg. Vertices W are the inputs (parents) and v is
the output (child).
The definitions of cycle, path, connectedness, di-
rected acyclic hyper-graph (DAHG) and sub(hyper-)graph are analog to that of a normal
graph.
We consider a special case of hyper-graphs. Those hyper-graphs have arcs representing
Boolean functions (Akutsu et al. (2003); Klamt et al. (2006, 2007); Saez-Rodriguez et al.
(2009, 2011)).
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1A B C D E
F
AND AND
2
A BC D E
F
AND
Figure 2.2: Graphical representation of Boolean hyper-graphs. Graph 1 corre-
sponds to the disjunctive normal form F = (A^B^:C)_(D^:E). Graph 2 corresponds
to F = (A ^B ^ :C) _D _ :E.
Definition 2.13 (Boolean directed hyper-graph (BG)). A directed hyper-graph G =
(V;A) is Boolean, if every arc e 2 A; e = (W; v), W = fw1; : : : ; wng defines a Boolean
function e : f0; 1gn ! f0; 1g, v = e(w1; : : : ; wn).
We can now write a Boolean directed hyper-graph as a set of disjunctive normal forms.
	 = (Si)i2IN with Si =
W
j
 V
k2JjI
Sk
!
(2.24)
where Si are the vertices of the graph.
When we talk about graphs, the term Boolean implies directed hyper-edges with one
or more parents per edge. Thus, from here on we refer to a Boolean directed hyper-graph
as a Boolean graph (BG) or network for short. If not stated otherwise, we visualize a BG
as a bipartite graph:
Boolean literals are drawn as circular vertices. AND clauses of a disjunctive normal
form are depicted by additional grey rectengular vertices all labeled with AND. We draw
an edge from every literal (inputs) in the clause directed into the AND vertex and from the
AND vertex into the output. For example the DNF D = (A^B^C) with inputs A;B;C
and outputD is converted to the normal graph f(A;AND); (B;AND); (C;AND); (AND;D)g
with the two diﬀerent vertex sets fANDg and fA;B;C;Dg. Several of these bipartite
edges combined correspond to the AND clauses combined by OR operators. Figure 2.2, 1
shows the hyper-graph representation of the DNF F = (A ^ B ^ :C) _ (D ^ :E) . If
a literal is negated in the DNF, we illustrate this by a red tee (a). If there is only one
literal in a clause, we omit the AND vertex (figure 2.2, 2).
In the rest of the thesis we do not distinguish between a clause in a DNF and the
corresponding (hyper-edge). For example if we write the edge C = A ^ B, we mean the
corresponding hyper-edge.
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3Network Models
A gene regulatory network visualizes relationships between genes as a graph. The graph
depicts on how genes regulate each other’s mRNA expression. An edge between two
genes denotes an association. An arc between two genes denotes a directed causal eﬀect
such as a change in expression of gene A causes a change in expression of gene B (A !
B). However the arc does not imply that a change in expression of B causes a change of
expression of A. In this chapter we give a short review of Bayesian Networks to infer gene
regulatory networks from gene expression data.
In section 3.2 we review a method, which does not infer a gene regulatory network, but
a signalling pathway. However, the inference of the pathway is based on an underlaying
gene regulatory network. In section 3.3 we review a method infering a signalling pathway
based on how proteins influence each others phosphorylation state.
3.1 Bayesian Networks
Bayesian Networks (BN, Heckerman et al. (1995); Neapolitan (2003)) describe causal
independences between a set of variables (X1; : : : ; Xn). For example gene A is indepenent
of B given C, if P (AjB;C) = P (AjC). In other words B does not provide additional
information on A, if we already know C.
A Bayesian network is parameterized by a directed acyclic graph (DAG) G and a joint
probability distribution D.
Notation:
• I(A;C1; : : : ; CnjB) denotes A is independent of C1; : : : ; Cn given B.
Figure 3.1 shows an example. Graph 1 defines the independences
I(A;E); I(B;DjA;E); I(C;A;D;EjB); I(D;B;C;EjA); I(E;A;D):
and joint probability distribution
P (A;B;C;D;E) = P (A)P (BjA;E)P (CjB)P (DjA)P (E):
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Figure 3.1: Bayesian Network. Two equivalent Bayesian networks (1, 2) and their
equivalence class (A).
In general, given a graph G = (fX1; : : : ; Xng ; E) we can write the joint probability
distribution
P (X1; : : : ; Xn) =
nY
i=1
P (XijPaG(Xi))
with PaG(Xi) as the parents of Xi.
Two graphs are equivalent if they define the same probability distribution. From the
definition of conditional probability follows:
P (A)P (DjA) = P (D)P (AjD):
Thus graph 1 is equivalent to graph 2, because both graphs define the same probability
distributions. Graph A shows a partially directed acyclic graph (PDAG) denoting the
equivalent class for both DAGs 1 and 2.
We score a given graph G against the gene expression data
D = (xij); i = f1; : : : ; ng ; j = f1; : : : ;mg
of m samples with the following score
S(G : D) = logP (GjD) = logP (DjG) + logP (G)
with
P (DjG) =
Z
P (DjG;)P (jG)d
and  as the conditional probability distributions of each variable Xi on its parents. This
marginal likelihood approach regularizes the score for the graph size.
We use search heuristics like genetic algorithms (Mitchell (1999)) or greedy hill-
climbing (Cormen et al. (2007)) to optimize the score.
3.2 Nested Eﬀects Models
Nested Eﬀects Models (NEM) (Markowetz et al. (2005)) are based on the concept of
signal flow. A protein signalling pathway is activated via stimulation of a receptor.
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The signal flows through the pathway from the membrane and via signalling molecules
downstream to transcription factors. The transcription factors become active and execute
or repress the transcription of their target genes.
Hierarchical relationships in the pathway are inferred from knock-downs of the path-
way players during stimulation. NEM makes the following assumption. The further up
a protein A is in the pathway the more target genes change their gene expression during
a knock-down of A. If the set of eﬀected genes of protein B is a noisy subset of the set
of eﬀects of protein A, we can conclude A upstream of B (A ! B). This relationship
implies an indirect knock-down of B every time we perform a knock-down of A.
3.2.1 Original approach
Markowetz et al. (2005) call the proteins that are part of the signalling pathway signalling
genes or S-genes. Let Sj be an S-gene, then j;k describes the eﬀect state of Sj during
knock-down of Sk. j;k = 1 denotes that the knock-down of Sk S-gene is aﬀected by the
knock-down of Sk, j;k = 0 denotes that it is not. In other words if we knock-down Sk,
we also knock-down or silence Sj (j;k = 1) or we don’t (j;k = 0). This relationship is
described as a silencing scheme via the adjacency matrix (i;j) = . i;j is also called
silencing eﬀect.
Activation of S-genes is not directly observed. The data consists of gene expression
profiles. Genes in the data which react to the perturbations are called eﬀector genes or
E-genes. Ei;k denotes the discretized foldchange between knock-down and control during
stimulation. Ei;k denotes whether E-gene Ei is aﬀected (1) by the knock-down of Sk
or not (0).  = (i) denotes the regulation of E-genes. i = j denotes Ei is directly
regulated by Sj.
An example of (;) is shown in figure 3.2. Due to noise, the observed data includes
false positives and false negatives with rates  and . Markowetz et al. (2005) use  and
 to calculate the following conditional probabilities:
P (Ei;k j; i = j ) =
Ei;k = 1 Ei;k = 0
 1   if  predicts no eﬀect
1    if  predicts eﬀect
: (3.1)
Diﬀerent silencing schemes  are scored against data D = (Ei;k)i;k with the marginal
likelihood approach.
P ( jD ) = P (D j)  P ()
P (D)
Let E-gene positions  be given. Since P (D) is the same for every silencing scheme and
P () is assumed uniform, we can write
P (D j;) =
mY
i=1
P (Di j; i ) =
mY
i=1
lY
k=1
P (Ei;k j; i ) (3.2)
where Di is the row of all eﬀects for E-genes i.
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Figure 3.2: Nested Eﬀects Model. Network for a silencing scheme of S-genes X, Y
and Z with their own exclusive set of E-genes attached to each (left). The eﬀects of
the respective knock-downs on the E-genes (right). The observed data diﬀers from the
expected due to false positives and false negatives.
Another assumption is the independence of the position of E-genes . In other words
the probability of E-gene i to be regulated by S-gene j is independent of the regulation
of all other E-genes. It follows
P ( j) =
mY
i=1
P (i j) : (3.3)
Moreover we assume an uniform prior probability for the attachment of an E-gene to
a S-gene.
P (i = j j) = 1
n
: (3.4)
 is unknown and therefore a marginal likelihood is calculated that averages over .
P (D j) =
Z
P (D j;)P ( j) d (3.5)
(3.2);(3.3)z}|{
=
mY
i=1
Z
P (Di j; i )P (i j) di (3.6)
(3.4)z}|{
=
1
nm
mY
i=1
nX
j=1
P (Di j; i = j ) (3.7)
(3.2)z}|{
=
1
nm
mY
i=1
nX
j=1
lY
k=1
P (Ei;k j; i = j ) : (3.8)
The error rates  and  are two free parameters.
3.2.2 Optimization
Exhaustive search for the optimal network describing the data is only feasible for a limited
number of S-genes. Markowetz et al. (2007) and Froehlich et al. (2007) developed
diﬀerent heuristics.
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Pairwise
The pairwise search (Markowetz et al. (2007)) infers pairwise relationships between
two S-genes (A;B). The four possible outcomes are A upstream of B (A ! B), B
upstream of A (B ! A), A and B are indistinguishable (A $ B) and A and B are
unconnected/unrelated (A::B). All models are scored and the best is selected.
The computation time of pairwise compared to the exhaustive search decreases es-
pecially for larger numbers of S-genes. However contrary to exhaustive search, pairwise
does not cover the complete search space and hence does not guarantee the global optimal
network. As a result Markowetz et al. (2007) also developed the triples search.
Triples
The triples algorithm consists of the following steps.
Algorithm 1 triples
1. score each possible network for each triple (A;B;C) and select the best
2. count how often each edge is chosen in all the triples and compute confidence score
f (A! B) = 1
n 2
P
C=2fA;Bg
1 ["A! B" 2MABC ],
with indicator function 1 [:] for the existence of edge A! B in the triplet MABC
3. edges that exceed a threshold (e.g. 0:5) are chosen for the final graph
Triples is computationally more expensive than pairwise, but achieves better results
(Markowetz et al. (2007)).
Module Networks
Another inference algorithm is called module networks (Froehlich et al. (2007)). The
method is based on the following notion. Knock-downs of S-genes which are in similar
parts of the pathway produce similar expression profiles which cluster together. These
clusters of S-genes can be further divided into smaller clusters.
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Algorithm 2 module network inference
1. cluster the complete set of S-genes into modules
2. further subdivide until the leaf modules of the cluster hierarchy have at most 4
S-genes
3. exhaustively search for the highest scoring graph for each leaf module
4. connect the leafs by their highest scoring pairwise connection and transitively close
the graph for each module
5. recursively do steps 3 4 until the complete connected network has been established
3.2.3 Factor Graph Nested Eﬀects Models
The original NEMs (Markowetz et al. (2005)) are limited to positive interactions. Factor-
Graph Nested Eﬀect Models (FG-NEM, Vaske et al. (2009)) directly extend the frame-
work by distinguishing between positive and negative interactions between S-genes, as
well as positive and negative regulation of E-genes (figure 3.3, A). This is achieved by
replacing the binary values of the silencing scheme  with six diﬀerent interaction modes.
1. A activates B; A! B
2. A inhibits B; AaB
3. A is equivalent to B; A = B
4. A does not interact with B; A 6= B
5. B activates A; B ! A
6. B inhibits A; BaA
The novel AaB interaction denotes if A is not knocked down (A = 0), it has an eﬀect on
B (B = 1). In other words B is inhibited.
Furthermore interaction modes are inferred from scatter plot profiles (figure 3.3, C).
A scatter plot of the observed E-gene data between two knock-downs A and B is divided
into nine regions: up/down-regulated by A and B (four regions), not regulated by A
and B (one region), regulated by one and not by the other (four regions). The observed
modes of E-gene profiles are compared with expected modes to infer the type of regulation
between two S-genes. The maximum a posteriori is used as objective function to identify
networks which maximize the networks respectively its modes  and E-gene regulation
.
J(X) =
max

8<:P () Y
e2E;A;B2S
max
eAB
X
YeA;YeB
P (YeA; YeB jAB ;eAB )P (XeAr jYeA )P (XeBr jYeB )
9=; : (3.9)
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YeA is the hidden discrete state of E-gene e during knock-down of A, XeAr is the observed
state in replicate r, eAB is the type of regulation for e by the pair A;B and P () is the
probability of the interaction model .
P () /
 Y
A;B;C2S
ABC (AB;AC ;BC)
! Y
A;B2S
AB (AB)
!
: (3.10)
ABC is the transitivity factor and AB a prior for the interactions. ABC is zero if a
triple A;B;C does not form a valid transitive structure (e.g. A ! BaC, A ! C) and
one otherwise.
Model inference
FG-NEM does model inference on a factor graph (Kschischang et al. (2001)). A factor
graph is a bipartite graph with factors and variables as vertices. A factor and a variable
are connected, if the factor includes the variable. A factor graph representing the example
from figure 3.3 is shown in figure 3.4. The factor-graph encodes all possible networks at
once. Variables (circles) are
• S-gene associations  = (AB)
• hidden E-genes expression states Y = (YeA) with YeA as the hidden, discrete E-gene
state of E-gene e during knock-down A and
• observed E-gene expressions X = (XeAr) with XeAr as the expression of E-gene e
in replicate r of knock-down A.
Factors (boxes) are expression factors, interaction factors and transitivity factors. Ex-
pression factors are Gaussian and connect the observed and the hidden E-gene state.
Interaction factors are the probabilities of the form
P (YeA; YeB jAB;eAB ) : (3.11)
The maximum a posteriori is found using equations (3.9) and (3.10) and max-sum
message passing (Kschischang et al. (2001)).
3.2.4 Dynamic Nested Eﬀects Models
Original NEMs are designed for static experiments. After each experiment, the signalling
pathway is assumed to be in a steady state. A steady state means every S-gene is in a
final state of either 0 or 1 and there is no further change. As a result original NEMs
cannot resolve feed forward loops. For example in case of the network A ! B ! C
the original NEM cannot determine if the eﬀect of A on C is direct or indirect via B.
Thus a feed forward loop from A! C is not resolvable under steady state assumptions.
Dynamic Nested Eﬀects Models (D-NEM, Anchang et al. (2009)) extends NEM and uses
timeseries data to infer time dependent signalling processes like feed forward loops.
Novel model parameters in D-NEM are the signalling rates K = (kij) of edges from
S-genes i to j (figure 3.5). They are assumed to be exponentially distributed. K replaces
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Figure 3.3: Predicting Pair-wise Interaction Using Quantitative Nested Eﬀects.
(A) Hypothetical example with four S-genes, A, B, C, and D. The graph contains one
inhibitory link, BxD (left). A heatmap of E-gene expression under knockdown of each
S-gene shows both inhibitory and stimulatory eﬀects (middle). Scatter plots of the C,
A, B, and D knock-outs show that expression fits in the shaded preferred regions of each
interaction (right). The inhibitory link explains some of the observed data: expression
changes under DD (bright red or bright green entries in the heatmap) occur in a subset
of the E-genes for which the opposite changes occur in DB. (B) Data from a known
inhibitory interaction. Expression levels of eﬀect genes under the DIG1/DIG2 knock-out
(y-axis) plotted against their levels under the STE2 knock-out (x-axis) as detected in
[17]. Expression changes significant at a = 0.05 indicated in gray lines. DIG1/DIG2 is
known to inhibit STE12. (C) Interaction modes. Observed E-gene expression changes are
compared to five possible types of interactions between two S-genes, A and B (iv). The
top row illustrates the expected nested eﬀects relationship for each type of interaction
mode: circles represent sets of E-genes with expression changes consistent with either
activation (blue circles) or inhibition (yellow circles). Scatter-plots for each interaction
mode show the hypothetical expression changes under DA (x-axis) and DB (y-axis) for
all E-genes (circles). E-gene levels are either consistent (filled) or inconsistent (open)
with the mode. Shaded regions demark expression levels consistent with each interaction
model. The example shows expression changes that most closely match the inhibition
mode (indicated by the greatest number of closed circles). This figure was reproduced
from Vaske et al. (2009).
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Figure 3.4: Structure of the factor graph for network inference. The factor graph
consists of three classes of variables (circles) and three classes of factors (squares). XeAr
is a continuous observation of E-gene e’s expression under A (knock-down of A) and
replicate r. YeA is the hidden state of E-gene e under A, and is a discrete variable with
domain fup; ; downg. AB is the interaction between two S-genes A and B. Expression
Factors model expression as a mixture of Gaussian distributions. Interaction Factors
constrain E-gene states to the allowed regions shown in Figure 3.3. Transitivity Factors
constrain pair-wise interactions to form consistent triangles. The arrows labeled  and
0 are messages encoding local belief potentials on AB and are propagated during factor
graph inference. This figure was reproduced from Vaske et al. (2009).
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Figure 3.5: Dynamic Nested eﬀects Model Elementary example of a D-NEM. Shown
is a network of three S-genes together with binary time series tables for typical E-genes
connected to the S-genes. Each table holds three rows corresponding to the three possible
perturbation experiments of S-genes. A one in column ti , row Sj of table Ek represents
the observation of a downstream eﬀect in Ek , ti time units after perturbation of Sj. This
figure was reproduced from Anchang et al. (2009).
the model parameters , which describe the S-gene topology. A large kij from S-gene i
to j corresponds to a high signalling rate and an edge between the S-genes. A small kij
objects any signalling from S-gene i to j. Therefore D-NEMs are parameterized by rate
constants K and S-gene to E-gene connectivity  as in 3.2.1.
The likelihood to score a candidate set K is defined as
P (DjK;) =
Y
D=1
PSi!Ek(ts)(1  ) + (1  PSi!Ek(ts))

Y
D=0
PSi!Ek(ts) + (1  PSi!Ek(ts))(1  ):
 and  are false positive and false negative rates. PSi!Ek(ts) is the probability, that the
signal from Si reaches Ek before timepoint ts. How this probability is calculated is shown
in the following example.
Let’s assume we have the path g with a simplified index for the rate constants:
Si
k1 ! Sj1   
kq 1  ! Sjq 1
kq ! Ek:
Zg is the sum of of q independent, and exponentially distributed random variables with
rate constants k1; : : : ; kq. Zg’s targeted probability is P (Zg < ts). The density function
of Zg is given by
	(t)g =
1Z
0
  
1Z
0

 
t 
qX
u=1
u
!
qY
u=1
	u(u)d1 : : : q
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with 	u() = ku exp( ku) as the density of an exponential with rate ku. A Laplace
transformation returns
Fg(t) =
qX
b=1
Y
a 6=b

ka
ka   kb

[1  exp( tkb)]
as a closed form for the cumulative distribution function of Zg. In the case of two or more
ku with equal values the right side can be undefined. Anchang et al. (2009) avoid this
by the use of small jitter values. Several paths can connect Si with Ek. For each path u
Zu is constructed as before and the probability is given by
PSi!Ek(ts) = 1 
Y
u
(1  Fu(ts)):
An optimal network model is inferred via a Gibbs sampling approach (George Casella
(1992)).
3.2.5 Partial Nested Eﬀects Models
Usually Nested Eﬀect Models assume, that the pathway is isolated. That is only S-
genes included in the model influence the signalling. This is not the case in general.
Literature is missing information on hidden players, which are not included in the model.
Additionally those players are not known to be missing. Sadeh et al. (2013) calls these
players unknown unknowns and introduce Partial Nested Eﬀects Models (P-NEM) as an
extension to the original NEMs to account for them.
P-NEM looks for patterns in the data, which contradict certain hypotheses (edges)
between two S-genes. For example let’s assume X is upstream of Y (M = X ! Y ).
E-genes reacting to Y but not X contradict that hypothesis, because if we knock-down
X we indirectly knock-down Y given M . These contradicting eﬀects are called a alien
patterns. Every alien pattern in the data is tested for significance with a binomial test.
Alien patterns exists for four of five diﬀerent edge relations between two S-gene (fig-
ure 3.6, a). Each relation has its unique set of alien patterns except for the one in which
X and Y have a common child (R5). This relation can explain all patterns.
For an example on how to detect significant alien patterns we look at relation R1.
Edge X ! Y (R1) has three expected patterns and one alien pattern (X;Y ) = (0; 1).
The alien pattern can be the result of an expected pattern and noise (expected
noisez}|{!
alien). If we consider a false positive rate  and false negative rate , we can calculate
the probability of each case:
• (1; 0)
noisez}|{! (0; 1) is the result of one false negative and one false positive and we have
a probability of 1 =   
• (1; 1)
noisez}|{! (0; 1) is the result of one false negative and one true positive and we have
a probability of 2 =   (1  )
• (0; 0)
noisez}|{! (0; 1) is the result of one true negative and one false positive and we have
a probability of 3 = (1  )  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We can now write an upper limit for the probability of more than k alien patterns in the
data, given relation R1:
P (K  k jX ! Y ) 
nX
i=k

n
i

iR1 (1  R1)n i (3.12)
n is the total number of E-genes and R1 an upper bound for the probability of observing
an alien pattern. Such a bound for the probability is available for all relations except for
R5, since it lacks an alien pattern. The other relations R1, R2, R3 and R4 are rejected if
P (K  k jRi) < 
with  as a cutoﬀ for significance, e.g.  = 0:05.
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Figure 3.6: Partial Nested Eﬀects Models Pairwise upstream/downstream relations
and their alien patterns: (Top) Shown are the five possible possible relations (R1) . .
. (R5) together with their expected silencing patterns and their alien patterns (grey
are NA values). R4 are disconnected S-genes without indirect connections. (Bottom)
Hidden vertices are introduced in all possible configurations, and the expected patterns
of E-genes attached to the hidden vertices are shown. In (R4) the hidden vertex marked
in red produces the alien pattern of (R4). Note that this constellation leads to the
constellation in (R5). Based on figure 2 in Sadeh et al. (2013).
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3.3 CellNet Optimizer
The CellNet Optimizer (CNO, Saez-Rodriguez et al. (2009, 2011)) uses phosphopro-
teomics data to infer the signalling logics of a protein pathways. The pathway is modelled
as a Boolean graph. Each vertex can be 1 or 0. The corresponding proteins are active
(1) or inactive (0). The graph edges correspond to diﬀerent Boolean functions. The base
functions are AND, OR and NOT. If two parent vertices are connected to a child vertex
with an AND-gate, both parents need to be active for the child to be active. If they are
connected by an OR-gate, one parent is enough to propagate the signal. In case of the
NOT-gate the parent needs to be inactive for the child to become active.
The CNO uses a prior knowledge network (PKN). The PKN denotes possible inter-
actions in a simple directed graph (figure 3.7, A). This graph is then processed to a
full hyper-graph. Unnecessary vertices are compressed (figure 3.7, C,D). For example if
vertex B is unobserved and the PKN includes the edges A ! B ! C, the two edges
are compressed to A ! C. Then all edges are processed to include all possible Boolean
functions derived from the PKN (figure 3.7, E). For example if the PKN includes edges
A ! C and B ! C the AND-gate A AND B ! C (DNF: C = A ^ B) is added. The
search space consists of all networks which are sub-graphs of the extended hyper-graph.
The experimental design of the input data combines stimulations and inhibitions.
Pre-set vertices are dependent of the design. For example if a receptor is stimulated in an
experiment its model vertex is set to 1. Similarly diﬀerent players in the pathway can be
inhibited and the associated model vertices are set to 0 independently from the rest of the
network. The states of all unset vertices, neither stimulated nor inhibited, are calculated
based on the pre-set vertices and the Boolean functions in a candidate network P . P is
scored against the data with the bipartite objective function (equation (3.13)).
(P ) = f (P ) + s (P ) ;
f =
1
nE
sX
k=1
mX
l=1
nX
t=1
 
BMk;l;t  BEk;l;t
2
:
(3.13)
BMk;l;t 2 f0; 1g is the model predicted state and BEk;l;t 2 [0; 1) the measured state of vertex
l at time t in experiment k. s penalizes the size of the candidate network P . The
number of tails of P is divided by the maximal number of tails in the network with all
possible hyper-edges. For example the AND-gate C = A ^ B gets the same size penalty
(2) as the OR-gate C = A _B.
3.3.1 Model inference with a genetic algorithm
Even with a medium sized network with 50 edges the complete search space holds 250 
1015 candidate networks. Exhaustive search is not feasible anymore and a fast search
heuristic is necessary.
A genetic algorithm (GA, Mitchell (1999)) is a stochastic search heuristic and borrows
mechanics from evolutionary biology to traverse the search space. GAs reach reasonable
convergence with relatively little time consumption. The general outline of a GA is the
following:
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Figure 3.7: CellNet Optimizer Assembly, calibration, and analysis of a toy signalling model.
(A) Signed directed graph representing a simple pathway as visualized using Cytoscape (Shannon et al.
(2003)). The topology of the reactions downstream of TGF and TNF receptors is imaginary, but
it includes real molecules such as Shc, Ras, Raf, MEK, ERK, PI3K, AKT, GSK3, IK, IB, NFB,
TRADD, caspase 8 (denoted C8), and the GrbSos complex (denoted GrbSos). (B) The design of the
synthetic experiments used to train the graph in panel A. Each column represents an experiment and
each row a diﬀerent designated species as follows: green denotes ligands, red denotes the protein targets
of kinase inhibitors, and blue denotes the proteins whose states were assayed (readouts). The presence
or absence of ligand or an inhibitor specific to a node is denoted with + and  , respectively. The 0/1
value for the readouts corresponds to the result obtained from simulating the reference model under
specific conditions of ligand and inhibitor exposure. (C) Rules applied to graphs to create compressed
representations. (D) The experimental design (B) determines which nodes in the graph are designated
and which are undesignated. This information, in combination with the rules in panel C was used
to create a compressed graph, with nodes eliminated by compression indicated by dashed lines. (E)
Superstructure of all models compatible with the graph in panel A. (F) Optimal models for size penalties
of 0    0:23. The highlighted panels to the right (boxed with dashed lines) show three diﬀerent logical
structures recovered during model calibration with  = 0. The fit to data was perfect for all models
(f = 0). (G) Optimal model for 0:23    0:75. The matrix below shows the single mismatch (in
red) between models based simulations and the training data. (H, I) Balance between the fit of the data
f (the MSE deviation from data; see text for details) and size s for models recovered using diﬀerent
values of the size penalty, . This figure was reproduced from Saez-Rodriguez et al. (2009).
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Algorithm 3 genetic algorithm
1. start with initial population of N networks (e.g. random)
2. score each network of the current population
3. create probability distribution for the current generation
4. sample pairs of networks from the current population and combine (e.g. uniform)
them to create a new population
5. with a (low) probability randomly change edges (mutation rate)
6. go to step 2 or stop (stop criteria: no improvement of the best score for n genera-
tions, timelimit, maximum number of generations, score based convergence).
The networks are encoded as binary vectors with an entry for each hyper-edge in
the search space. 1 encodes the hyper-edge as present in the current network and 0 as
absent. Two vectors of parent networks A and B are combined to a child C via an uniform
selection. In other words for each hyper-edge entry we draw a uniform number r. If r is
smaller or equal to 0:5, C gets the entry of A. If r is greater than 0:5, C gets the entry
of B.
Stochastic Universal Sampling
The GA algorithm constructs the probability distribution of the network population with
stochastic universal sampling (SUS) (algorithm 4). SUS uses a linear fitness function, a
special case of rank selection (Mitchell (1999); Baker (1985)), with a selection pressure
parameter '. The chance for the best network to be chosen for reproduction is ' times
the chance of the average network.
Algorithm 4 stochastic universal sampling
1. score each network of the current population of size N and rank them from worst
(1) to best (N)
2. based on selective pressure ' calculate fitness i for each network i 2 f1; : : : ; Ng
' 2 [1; 2], i = 2  '+
 
2 ('  1) i 1
N 1

3. set interval limits !0 = 0, !i =
iP
j=1
i
NP
k=1
k
and breaks bi = r  1N + i 1N with random
number r  U(0; 1)
4. si = l if and only if bi 2 [!l; !l+1) for l 2 f1; : : : ; Ng
S = (si) is now the empirical distribution.
28
2 4 6 8 10
0.
0
0.
5
1.
0
1.
5
2.
0
rank
ch
an
ce
 fo
r 
re
pr
od
uc
tio
n 
in
 re
sp
ec
t t
o 
th
e 
av
e
ra
ge
 c
ha
nc
e
Figure 3.8: Example for linear and non-liner fitness. Fitness curves for linear (black)
and non-linear (red) fitness with selection pressure 2 for a population of 10 networks. The
fitness value (y-axis) describes the chance to be chosen for reproduction in respect to the
average network. With a selection pressure of 2 the best network is on average chosen
twice as often as the average network.
Non-linear fitness (Pohlheim (1995)) is an alternative to linear fitness and more equally
balances exploitation and exploration. Exploitation is the convergence of the current so-
lutions in the local neighbourhood. Exploration introduces more variance in the solutions
to investigate a larger search area.
For population size N we can choose selection pressure  2 [1; N) . The fitness i is
then calculate the following way:
i =
N  xi 1
NP
j=1
xj 1
for the root x of the polynomial
0 = ( N)  xN 1 +   xN 2 +   +   x+ :
An example for the diﬀerence between linear and non-linear fitness is shown in figure 3.8.
An example for the calculation of the si (section 3.3.1) for a population of 10 networks
is shown in figure 3.9.
Tournament Selection
Unbiased tournament selection (UTS, Sokolov & Whitley (2005)) is an alternative to
stochastic universal sampling (SUS). UTS eliminates the selection pressure parameter
and can be computed more eﬃciently. UTS also guarantees that the sampling set always
includes the best network twice and never the worst.
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fitness values for the population (linear scaling)
0.00 0.07 0.13 0.22 0.33 0.47 0.62 0.80 1.00
fitness values for the population (non−linear scaling)
0.04 0.14 0.21 0.28 0.38 0.50 0.63 0.80 1.00
Figure 3.9: Example for stochastic universal sampling and (non-)linear fitness.
On the x-axis, we see the calculated values for !i; i 2 f1; : : : ; 10g. The red lines mark the
values for the randomly selected bi; i 2 f1; : : : ; 10g. The bi are the same in both, but the
!i are scaled diﬀerently (top: linear, bottom: non-linear). The medium ranked networks
have a smaller chance with non-linear selection pressure, but the lowly ranked networks
have a higher chance.
Algorithm 5 tournament selection
1. score each network of the current population and rank them
2. permute the ranks with permutation p such that i 6= p (i) 8i
3. add i to the sample distribution , i has a higher score than p (i);
add p (i) to the sample distribution , p (i) has a higher score than i.
We ensure that after the permutation in step 2 it holds i 6= p (i) with the following
permutation. First permute the ranks. These randomly ordered ranks are the new
unpermuted ranks. Next we shift them by one position with the last rank becoming the
first. The tournament size k 2 N; k > 1 can be set larger than 2. This way the best
network is included k times in the sampling set.
The GA can be divided in an embarrassingly parallel problem. The scoring of the
networks in step 2 of the GA (3) is independent. Thus the GA can be parallelized on
up to N threads for population size N . We can further parallelize the creation of the
probability distribution (algorithm 4 , step 4 and algorithm 5, step 3).
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4Boolean Nested Eﬀects Models
Parts of this chapter have been published (Pirkl et al. (2016)).
4.1 Complex and Alternative signalling
It is crucial to understand signalling pathways of cells to battle diseases like cancer (Du-
four & Clavien (2005)). Current computational methods are not general enough to reach
a high resolution from steady state experiments. We aim to use these experiments to
increase pathway resolution and resolve complex signalling structures.
4.1.1 Combinatorial signalling
Signals in a pathway are not just transduced in a straight line from protein A to B to
C and so on. Proteins are activated and repressed in many diﬀerent ways. For instance
two or more proteins can form a complex to activate another protein. This complex is
depending on all members to function correctly. If one part of the complex is broken
or missing, the signal will not be propagated anymore. In contrast during alternative
signalling several diﬀerent pathway members can propagate the signal independently
from each other to the target protein. If one of them is broken or missing, the others will
cover for it. This redundancy makes the whole signalling pathway more robust against
perturbation. These two phenomena can be combined to build arbitrarily complicated
signalling pathways.
Boolean networks have been successfully used to model complex formation and alter-
native signalling (Klamt et al. (2006, 2007); Saez-Rodriguez et al. (2009, 2011)). The
complex formation corresponds to the logical AND-gate and the alternative signalling to
the logical OR-gate. Furthermore, the logical NOT-gate is used to model the repression
or inhibition of one protein by another.
Any combination of AND-,OR- and NOT-gates is possible to describe the signal trans-
duction. An increasing number of proteins leads to an increasing number of combinations.
The number of combinations defines the size of the search space. Additionally, there are
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combinations which describe diﬀerent pathways, but the same Boolean logic. For instance
if A activates C either in a complex with B or alone, the corresponding Boolean network
as DNF is
C = A _ (A ^B) = A:
The complex formation of A and B cannot be resolved. This equivalence between diﬀerent
networks is also dependent on the experimental design. If only single knock-downs are
available, the two networks
G1 = fA = S;B = S;C = A _Bg and G2 = fA = S;B = S;C = Sg
are equivalent, because the signal from S to C is not blocked by a single knock-down of
A or B. A double knock-down on the other hand inhibits A and B and subsequently also
C.
Single knock-downs:
G1 : C = A _B = 0 _ S = 0 _ 1 = 1
G1 : C = A _B = S _ 0 = 1 _ 0 = 1
G2 : C = S = 1
Double knock-down:
G1 : C = A _B = 0 _ 0 = 0
G2 : C = S = 1
The size of the search space and equivalence classes are the two main challenges.
Technologies will become cheaper. Thus a lot more experiments with diﬀerent combina-
torial perturbations can be conducted and the size of equivalence classes will be reduced.
Furthermore we use prior knowledge to exclude network hypothesis beforehand, which
also reduces the size of equivalence classes and the search space. Then we traverse the
search space with a combination of eﬃcient search heuristics.
4.2 Pathway model and score
4.2.1 Signalling Pathways and Deterministic Boolean Networks
Molecular signalling pathways can be described as Deterministic Boolean Networks (Saez-
Rodriguez et al. (2009)). Networks are encoded as directed acyclic hyper-graphs 	 =
(S;H) consisting of a set of nodes S = (S1; : : : ; SN) and a set of Hyper-edges H =
(H1; : : : HM). Every node Si represents a signalling protein that can be either active
(Si = 1) or inactive (Si = 0). Hyper-edges describe how the signal is propagated through
the network. Every directed hyper-edge Hj connects one or more parent nodes with a
single child node. Hyper-edges with one parent node specify whether the child is activated
or repressed by its parent. Hyper-edges with more parents specify a unique activation
pattern of the parent nodes that is required for activating the child. If a node has multiple
incoming hyper-edges, it can be independently activated by all of them. Hence, every
hyper-edge with more than one parent node encodes an AND gate and multiple hyper-
edges with the same child form OR gates (Figure 4.1). Signalling pathways form AND
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gates, if multiple proteins need to be jointly activated to propagate the signal to their
target molecule. This is often associated with the formation of larger protein complexes.
OR gates in contrast occur when signalling is organized in a redundant manner. As with
Bayesian networks and NEMs, we assume that the real graph is acyclic. This limits the
scope of the method to models of signalling pathways in which the signal is propagated
from receptors via branching cytosolic eﬀector pathways into the nucleus without feedback
loops.
4.2.2 Experimental design and data
Our goal is to estimate the signalling pathway model 	 from a dataset D. The data
consist of K gene expression profiles (D(1); : : : ; D(K)) from a set of functional assays
with specific perturbations of the pathway. We assume that the expression data is on a
logarithmic scale. Perturbations include the exogenous stimulation of pathway receptors
and the inhibition of signalling components. Every profile D(k) is hence associated with
a specific experimental condition C(k) that specifies which receptors were stimulated and
which signalling genes were inhibited. This is the typical experimental set-up of NEMs
(Markowetz et al. (2005, 2007)). Following the NEM literature, we call the signalling
pathway components S1; : : : Sn S-Genes and the genes that show expression changes in
response to perturbations E-Genes. S-genes and E-genes can but need not overlap.
4.2.3 Expected and Observed Response Schemes
For a given hyper-graph 	 and a given condition C(k), we can calculate the activation
states of all nodes in 	 as follows: (i) root nodes are initialized to zero, (ii) stimulated
nodes are set to 1 and inhibited nodes are set to 0 independently of any incoming signals
from parent nodes, (iii) all other nodes are determined by propagating activation states
through the directed acyclic graph using the Boolean functions defined by the hyper-
edges of 	. Let C = (C(1); :::; C(K)) be the set of all experimental conditions, and
A  CC a set of comparisons between pairs of conditions. For every pair of conditions
i = (C(k); C(l)) 2 A we can determine, whether the expected activation of an S-gene
is identical under both conditions or not. We set ij = 0, if the predicted state of Sj
is identical under Ck and Cl. We set ij = 1, if Sj was switched on, i.e if it is inactive
under Ck but active under Cl and we set ij =  1, if Sj was switched oﬀ. We call  the
Expected Response Scheme (ERS) of 	 (Figure 4.1, middle).
Analogously, we organize the observed responses. For a given E-gene Ej, let i;j be
the expression change of Ej in comparison i. We call  the Observed Response Scheme
(ORS).
4.2.4 Scoring hyper-graphs
For a given hyper-graph 	, we want to score how well its expected responses  match
the observed responses . This cannot be done directly, because  refers to activation
states of S-genes, while  refers to downstream eﬀects in E-genes. Following the NEM
literature (Markowetz et al. (2005); Tresch & Markowetz (2008)), we assign E-genes to
S-genes. For every E-gene E we search the S-gene for which the expected responses (S)
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S0
S1 S2
S3
S4
AND
  H1    H2  H3
H4      H4
 H5
H4 
expected
 S−gene response scheme
(S0+) vs (S0+,S4−)
(S0+) vs (S0+,S3−,S4−)
(S0+) vs (S0+,S3−)
(S0+) vs (S0+,S2−,S4−)
(S0+) vs (S0+,S2−,S3−,S4−)
(S0+) vs (S0+,S2−,S3−)
(S0+) vs (S0+,S2−)
(S0+) vs (S0+,S1−,S4−)
(S0+) vs (S0+,S1−,S3−,S4−)
(S0+) vs (S0+,S1−,S3−)
(S0+) vs (S0+,S1−,S2−,S4−)
(S0+) vs (S0+,S1−,S2−,S3−)
(S0+) vs (S0+,S1−,S2−)
(S0+) vs (S0+,S1−)
(Control) vs (S4−)
(Control) vs (S3−)
(Control) vs (S2−)
(Control) vs (S1−)
(Control) vs (S0+)
S0 S1 S2 S3 S4
observed
 E−gene response scheme
(S0+) vs (S0+,S4−)
(S0+) vs (S0+,S3−,S4−)
(S0+) vs (S0+,S3−)
(S0+) vs (S0+,S2−,S4−)
(S0+) vs (S0+,S2−,S3−,S4−)
(S0+) vs (S0+,S2−,S3−)
(S0+) vs (S0+,S2−)
(S0+) vs (S0+,S1−,S4−)
(S0+) vs (S0+,S1−,S3−,S4−)
(S0+) vs (S0+,S1−,S3−)
(S0+) vs (S0+,S1−,S2−,S4−)
(S0+) vs (S0+,S1−,S2−,S3−)
(S0+) vs (S0+,S1−,S2−)
(S0+) vs (S0+,S1−)
(Control) vs (S4−)
(Control) vs (S3−)
(Control) vs (S2−)
(Control) vs (S1−)
(Control) vs (S0+)
E1 E2 E3 E4 E5 E6 E7 E8 E9 E1
0
Figure 4.1: Hyper-graphs and their response schemes The two matrices are an
expected S-gene response scheme of the S-genes and a hypothetical noisy continuous
observed E-gene response scheme of attached E-genes for the hyper-graph left. Black
matrix entries indicate up-regulation (+1), white down-regulation (-1) and gray no change
(0). Each column is a response scheme of an S-gene respectively E-gene. The rows are
comparisons between two conditions. In a condition + denotes the activation of the S-
gene and   the inhibition independent of the state of the parents. The set of modelled
comparisons is restricted to the typical design of a nested eﬀect model. Included are
comparisons of stimulation vs. control and stimulations + inhibitions vs. stimulations
only. S0 is a receptor that can be activated. The other S-genes propagate the signal and
can be inhibited. The edge H4 is an AND gate with two parents. S4 is activated by H4,
if S1 is active and S2 inactive. Alternatively, the inhibition of S3 can activate S4. Hence
H4 and H5 implicitly form an OR gate.
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match observed responses (E) best. We quantify this match by an association score
A between expected and the observed responses considering negative regulation. That
means the fit between S-gene and  (E). If not said otherwise we use the Spearman
rank correlation A = . Finally, we score the hyper-graph by balancing its data fit with
its size:
L(	) = 1
m

X
E
max
S
fA((S);(E));A((S); (E))g
    1
M

X
H2	
#pa(H)
(4.1)
The first sum runs over all E-genes and the second sum runs over all hyper-edges in
	. #pa(H) is the number of parent nodes of hyper-edge H.  > 0 is a parameter to
calibrate the penalty for network size. The network size penalty is identical to that used
in Saez-Rodriguez et al. (2009). m is the number of E-genes used in the score and M is
the maximal network size possible. This way the score normalizes to [0; 1] and the size
penalty to [0; ]. This makes  independent of the number of E-genes or the overall size
of the fully connected network.
4.2.5 Assigning E-genes to S-genes
It is interesting to know, which S-genes influences certain E-genes the most. For example
the expected response scheme of NfB should be most similar to the observed response
schemes of known NFB targets. Thus we calculate the subnetwork of pairwise regulation
of E-genes by S-genes.
 = fi;j : i;j 2 f 1; 0; 1gg describes the type of regulation (negative, no, positive)
of every E-gene j by every S-gene i. A posteriori we attach every E-gene to the S-gene it
is most similar to by setting
i;j =
8>><>>:
+1 :, max
(Sk)k
fA ((Sk);(Ej)) ;A ((Sk); (Ej))g = A ((Si);(Ej))
 1 :, max
(Sk)k
fA ((Sk);(Ej)) ;A ((Sk); (Ej))g = A ((Si); (Ej))
0 : otherwise
:
In other words if E-gene j’s ORS is most similar to S-gene i’s ERS, Si is defined as the
direct regulator of Ej and i;j = 1. Otherwise we set k;j = 0. If (Si) is most similar
to the actual foldchanges (Ej), the sign is positive and if Si is most similar to  (Ej),
it is negative.
One E-gene can be ambiguously attached to several S-genes, if the association scores
for these S-genes are all equal. We can also use prior information to a priori attache
E-genes to S-genes or exclude some S-genes as possible regulators for a set of E-genes.
4.2.6 Model adaptive discretization score
The original NEM infers networks from discretized data. It is not trival to find the correct
cutoﬀs for down regulation (-1), up-regulation (1) and no regulation (0). Thus we define
a more flexible score which discretizes the data dependent on the ERS.
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Figure 4.2: Example: model adaptive discretization. The blue foldchange larger
than  is always discretized as a 1 and either rewarded, if the model predicts a 1 or
penalized otherwise. The yellow foldchange is smaller than  and rewarded, if the model
predicts a 0 and penalized otherwise. The green foldchange (adaptive eﬀects) between 
and  is both rewarded if the model predicts a 1 or a 0 and only penalized if the predicted
eﬀect has a diﬀerent sign. ! is a weight parameter for predicted and observed 0s.  is the
weight parameter for the adaptive eﬀects.
For each pair of experiments l 2 A we define the model adaptive discretization
(MAD, (4.2)). Let il be the expected response of Si for l and jl the observed re-
sponse of Ej. We define
MAD (il;il) =
jlnil =  1 = 0 = 1
<   1    !  
2 [ ; ) 1   1    !    
2 [ ; ]      ! 1  !      !
2 (; ]     1    ! 1  
>       ! 1
: (4.2)
;  2 R;    are two cutoﬀs for the observed responses. If jl is greater than  it is
always discretized as a positive (1) respectively lesser than   negative ( 1) eﬀect. It
is rewarded with 1, if it is in conformity to the predicted state of Si and penalized with
 , if it is not. If a foldchange is smaller than jj, it is always discretized as no eﬀect (0)
and rewarded respectively penalized the same way. If a foldchange is in the transition
phase between  and  respectively   and  , it depends on the model prediction. If
the model predicts an eﬀect for the S-gene, the foldchange is also discretized as an eﬀect
and rewarded including a weight factor . If the model predicts no eﬀect the E-gene is
discretized as no eﬀect. ! is a weight factor for predicted and observed zeros (no eﬀects).
The parameters ! and  are similar to false positive and false negative rates.  < 1: the
further the E-gene diﬀers from the predicted S-gene value the smaller the score. ! < 1:
false negatives are more likely than false positives. An example is shown in figure 4.2.
Based on the MAD score we define a new association score:
A ((Si);(Ej)) = 1
M
X
(l2A)
MAD (il;jl) :
M 2 N is the maximal number of comparisons made. For example M = 19 in figure 4.1.
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Figure 4.3: Conditional probability. Toy example for the conditional probability of
(4.3). The figure is analog to figure 4.2 for the MAD score.
4.2.7 Marginal Likelihood Formulation
Similar to the MAD score, we can extend the marginal likelihood in Markowetz et al.
(2005). Let  be the expected response scheme, il the observed response of Ei to the
pair of experiments l 2 A and  the regulation of E-genes by S-genes. We define the
extended conditional probability by
P (il jl 2 A;; i;j = 1) =
il >    il >    il      > il      > il
1 
4P
i=1
i 1 2 3 4 if  predicts positive eﬀect
2 1 1  2
2P
i=1
i 1 2 if  predicts no eﬀect
4 3 2 1 1 
4P
i=1
i if  predicts negative eﬀect
: (4.3)
1; 2 are false positive and 1; 2; 3; 4 false negative rates. We assume symmetrically
distributed error rates. We can further simplify, if we assume a dependence between the
betas respectively alphas, like i = 1i ; 8 i 2 f1; 2; 3; 4g and 2 = 12 .
Analog to (3.8), we can write the marginal likelihood as
P (D jA;) = 1
nm
mY
i=1
nX
j=1
lY
k=1
P (ik jk 2 A;; i;j = 1) (4.4)
If we take the absolute of the observed responses il and set the cutoﬀs  = , (4.3) is
the same conditional probabilities as (3.1) in the original NEM.
4.2.8 Other Similarity Measures
There are several other measures for similarity, which can be used in equations (4.1) and
(4.5). Cosine similarity (Sidorov et al. (2014)) makes the score scale invariant. Diﬀerent
types of correlation (Fahrmeir et al. (2007)) add shift invariance. We also can think of
the E-gene to S-gene relationship as a classification problem. We have n S-genes with
n diﬀerent labels and m unlabeled E-genes. Supervised learning methods (e.g. support
vector machines, Chang & Lin (2011); Vapnik (1998)) find the best fitting S-gene for
every E-gene and can also calculate a probability as similarity measure.
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4.2.9 Automatic E-gene Selection
The previously defined score in equation (4.1) uses every E-gene regardless of goodness
of fit. However if an E-gene has no high similarity to any S-gene, it might not be involved
in the pathway. Therefore we add an automatic selection process to the algorithm similar
to the extra vertex introduced in Tresch & Markowetz (2008). In a filtering step the score
includes only E-genes, which exceed a certain threshold of similarity (fitness) to at least
one S-gene. For this we change the score from (4.1) to
L(	) = 1
m

X
U
max
S
fA((S);(E));A((S); (E))g
    1
M

X
H2	
#pa(H);
U =
n
E : max
S
fA((S);(E));A((S); (E))g > 
o
:
(4.5)
 2 [0; 1) is a cutoﬀ for the minimal fitness. Note that the normalization factor m is
independent of . Thus a network fitting only one E-gene with a fitness of 1 has the same
score as an equal sized network fitting two E-genes with a fitness of 0:5 each.
4.2.10 Local residuals
Even though we give each network candidate a score ((4.1),(4.5)) we do not know exactly
how well it explains the data. The network might explain parts of the data perfectly and
other parts not at all.
We can check how well a network fits the data by directly comparing the observed
response scheme with the expected response scheme. However if we use a scale invariant
association score (e.g. correlation), the eﬀects in the ORS might be too small to see
with the naked eye. If we have a high number of E-genes, it is also hard to visualize the
data. For that reason we introduce an approach to visualize local mismatches (residuals)
between ORS and ERS independently of eﬀect strength and number of E-genes. The
residuals solely depend on the score. Thus two diﬀerent scores can produce diﬀerent
residuals. For example Pearson’s correlation is shift invariant, but the euclidean distance
is not. Let the relation between the ERS i of S-gene i and the ORS (Ej) of E-gene j
be i = (Ej) + c with a constant c. Thus if we use correlation, it’s a perfect fit. If we
use distance we get a residual i  (Ej) = c.
We calculate residuals between a candidate network’s ERS and the ORS in the fol-
lowing way. We manipulate a single entry of the ERS and score it again. If the score
improves, the network has a residual at the position we changed. For example our net-
work predicts il = 1 for S-gene i and the pair of experiments l 2 A. We do not change
the network but the ERS: il = 0 or il =  1. If the new score improves, the E-genes’
ORS prefers a 0 respectively  1 instead of the network predicted 1.
Let (Ek)k2f1;;lg be the set of E-genes assigned to S-gene Si (i;k = 1). We calculate
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the local fitness score F for S-gene Si the following way:
F (Si) =
lX
k=1
max fA((Si);(Ek));A((Si); (Ek))g
=
X
E
ji;Ejmax fA((Si);(E));A((Si); (E))g :
We change a single eﬀect il for a pair of experiments l 2 A and S-gene Si in the ERS.
This results in two locally changed ERSs.
+ix =
8<:
ix : x 6= l
1 : ix 2 f0; 1g ; x = l
0 : ix = 1; x = l
 ix =
8<:
ix : x 6= l
 1 : ix 2 f0; 1g ; x = l
0 : ix =  1; x = l
:
In other words we change +il to 1, if it is negative (-1) or zero and to zero, if it positive
(1). We change  il to -1, if it is positive or zero and to zero, if it negative (-1). Then we
calculate the new local fitness scores for Si:
F+l (Si) =
lX
k=1
max
A(+(Si);(Ek));A(+(Si); (Ek))	
F l (Si) =
lX
k=1
max
A( (Si);(Ek));A( (Si); (Ek))	
If either F (Si) < F+l (Si) or F (Si) < F l (Si), Si has a residual at position l.
F+ =  f+il = F+l (Si) F (Si) and F  =  f il = F l (Si) F (Si) is the positive (PRM)
respectively negative residuals matrix (NRM). A positive matrix entry denotes the im-
provement of the fitness by a local change in the ERS. This helps to identify parts of the
data which are explained by our optimal network and parts that aren’t.
In practice we set all negative matrix values to zero, because changes at these positions
do not improve the score. Then we multiply all matrix entries with -1 which have been
changed to zero. Figure 4.4 shows an example for a PRM.
4.3 Optimization
Eﬃcient optimization is important for the learning of Boolean networks. Apart from a
fast and eﬃcient search algorithm, the design of the experiments has also consequences
on the identifiability of the optimal network.
4.3.1 Network Equivalence
Like Bayesian networks and standard NEMs, B-NEMs are aﬀected by likelihood/score
equivalence. It is possible that two diﬀerent networks have the same ERS . If in addition
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Figure 4.4: Hypothetical positive residuals matrix. Columns are pairs of experi-
ments l 2 A. Rows are S-genes. Non-zero values indicate a score improvement. Green:
the ERS has been changed from 0 or -1 to 1. Red: the ERS has been changed from 1
to 0. For example the E-genes fit better if a network predicts a positive eﬀect for S-gene
S5 for the pair of experiments “(control) vs (S0+)”. They fit worse, if a network predicts
no eﬀect instead of a positive eﬀect for S-gene S2 at position “(S0+) vs (S0+,S5-)”. The
E-genes regulated by S1 do not produce any residuals. The pair “(S0+) vs (S0+,S5-)”
does not produce any residuals either.
the networks have identical size, they yield identical scores no matter what the data looks
like. If not the smaller network is chosen. Note that  depends on the design of the set
of perturbation assays C. Two networks can be distinguished by one experimental design
but not by another. Figures 4.5 and 4.6 give examples, how the design can (i) aﬀect score
equivalence classes and (ii) aﬀect the optimal scoring network. Interestingly, in figure 4.5
we need an experiment involving only S3 during stimulation of S0 to correctly identify
the signalling logic of S4. In figure 4.6 the double knock-down of S1 and S2 resolves the
equivalence.
The following definitions formally introduce equal networks and (minimal) equivalence
classes in the context of B-NEM.
Definition 4.1 (network equality). Two networks 	1 = (Si)i2I and 	2 = (Si)i2I are
identical or equal, if and only if both define equal* Boolean functions for every Si; i 2 I.
In this case we write 	1 = 	2.
*) Two Boolean functions f and g are equal, if f = g by the rules (2.3) (2.21).
For two networks 	1 = (Si)i2J1I and 	2 = (Si)i2J2I with an overlapping set of
S-genes (J1 \ J2 6= ;) and a set of conditions C, we write Sij	j ;k for the state of S-gene
Si given its Boolean function in 	j and the condition k 2 C.
Definition 4.2 (network equivalence). Two networks 	1 = (Si)i2I and 	2 = (Si)i2I are
equivalent for a given set of conditions C, if and only if Sij	1;k = Sij	2;k 8i 2 I; k 2 C.
For the equivalence class of a network 	 we write [	].
A similar definition of equivalence as above but for NEMs was already introduced in
Tresch & Markowetz (2008).
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Figure 4.5: Missing single knock-downs. The response schemes of the two networks
diﬀer only for the experiment marked by the arrow. If that experiment was missing the
response schemes would be identical and the left network would score higher due to its
smaller size no matter what the data looks like.
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Figure 4.6: Missing double knock-downs. The response schemes of the two networks
diﬀer only for the experiment marked by the arrow. If that experiment was missing the
response schemes would be identical and the right network would score higher due to its
smaller size no matter what the data looks like.
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Definition 4.3 (minimal equivalence class). We call [	] minimal, if and only if for every
pair (	1;	2) 2 [	] [	] it follows, that 	1 = 	2.
The following definition introduces the concept of standard experiments. These ex-
periments are a generalization of the usual set of experiments used by NEM. NEM is
applied to data derived from experiments consisting of positive (stimulation) and nega-
tive control, and single knock-downs during the stimulation.
Definition 4.4 (standard experiments). Experiments in which a subset of S-gene(s) is
stimulated and a subset of S-genes knocked down (inhibited) during stimulation are called
“standard”, if and only if
• the inhibited S-genes are downstream of the stimulated S-genes
• the stimulated S-genes have no parents
Stimulations are denoted by a + (stimulation(s)+), knock-downs by a   (S-gene(s) )
and we call the negative control just control. The standard set of contrasts is:
• (Control) vs (stimulation(s)+)
• (stimulation(s)+) vs (stimulation(s)+,S-gene(s) )
Restricting the search space using prior knowledge
If the data can not distinguish between competing networks it is still possible that ex-
isting domain knowledge can. Like Saez-Rodriguez et al. (2009) we represent pathway
knowledge by a priori restrictions of the network search space. With this restrictions we
do not only reduce network ambiguity due to score equivalence, but also ensure that the
constructed networks follow general conventions of modelling signalling pathways (e.g.
the signal is propagated from receptors, via cytosolic molecules to nuclear factors). We
encode prior knowledge by a directed graph G whose edges are a collection of all links
between S-genes that are a priori possible. In other words, it is the missing edges of G
that define the search space restriction. We refer to G as a PKN. PKNs are then extended
to a Boolean network by adding hyper-edges such that all Boolean functions allowed in G
are a priori possible (figure 4.7). Hence, while B-NEM use help from prior knowledge to
estimate the network structure or topology they infer logical gates only from data. Using
prior knowledge can resolve score equivalence problems, but there is no guarantee that it
always does.
A priori set of experiments
Akutsu et al. (2003) already have done theoretical work for upper and lower bounds of
the number of experiments necessary to resolve the boolean functions of an underlying
genetic network. We give an example for a PKN with two S-genes directly regulating a
third and the type of perturbations necessary to resolve minimal equivalence classes.
Figure 4.7 shows a simple four S-gene example for a prior network (A) and its extension
(B). S0 is the stimulation and S1; S2 and S3 are potential knock-down targets. Graphs
1-5 in figure 4.7 are five subgraphs of graph B representing the minimal equivalence
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Figure 4.7: PKN extension and search space. Prior graph (A) and its extension (B).
Equivalence classes representing all possible networks regulating S3 (1-5).
classes. We show that a standard set of experiments with single knock-downs is suﬃcient
to resolve all five classes.
In the following enumerations, when we write regulated by Sn, we mean the stimu-
lation or knock-down and not the S-gene Sn. For example if the S-gene S1 positively
regulates S2 (i.e. S1! S2), the knock-down of S1 down-regulates S2 during the stimu-
lation.
1. S3 is up-regulated by the S0 stimulation and down-regulated by the S1 knock-down,
but not the S2 knock-down
2. S3 is up-regulated by S0 and down-regulated by S2, but not S1
3. S3 is not regulated by S0 and not regulated by either
4. S3 is up-regulated by S0 and not regulated by either
5. S3 is up-regulated by S0 and down-regulated by both
We show an example without feed forward loops, because they are diﬃcult to infer
with standard experiments. Figure 4.8 shows an example. The stimulatory signal to S3
in networks A and B can be blocked with single knock-downs of S1 and S2. Thus A and
B are equivalent ([A] = [B]) for standard experiments. An additional experiment with
the stimulation (knock-in) of S2 and a knock-down of S1 resolves the equivalence. The
S2 knock-in makes S3 independent of S1 in network A, but not in B (equation (4.6)). In
network B, S3 needs active S1 to be active itself.
A : S3 = S2 = 1
B : S3 = S1 ^ S2 = 0 ^ 1 = 0 (4.6)
The OR feed forward loop (D) is similar. The signal can be blocked by a knock-down
of S1, but not by S2. Thus the networks C and D are equivalent. Once more the single
knock-in of S2 combined with the knock-down of S1 resolves the equivalence (equa-
tion (4.7)).
C : S3 = S1 = 0
D : S3 = S1 _ S2 = 0 _ 1 = 1 (4.7)
Negative regulation increases the complexity of the search space in example 4.7. If
S1 and S2 have the potential to negatively regulate S3 (S1aS3, S2aS3), the number of
minimal equivalence classes is more than three times as high (figure 4.9).
43
AS0
S1
S2
S3
B
S0
S1
S2
S3
AND
C
S0
S1
S2 S3
D
S0
S1
S2
S3
Figure 4.8: AND-gate feed forward loop. (A) The signal to S3 can be blocked by
S1 or S2. A knock-in of S2 makes S3 independent of S1. (B) The signal can be blocked
by S1 or S2. A knock-in of S2 does only activate S3, if S1 is active, too. (C) Only S1
activates S3. (D) A knock-in of S2 activates S3 independently of S1.
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Figure 4.9: Search space including negative edges. Minimal equivalence classes
representing all possible networks with negative edges into S3. The blue edge on the right
denots ambiguous regulation, which means S3 is always active and only down-regulated
by its own knock-down.
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6. S3 is down-regulated by the S0 stimulation and up-regulated by the S1 knock-down,
but not the S2 knock-down
7. S3 is not regulated by S0 and down-regulated by S2, but not S1
8. S3 is not regulated by S0 and up-regulated by S1, but not S2
9. S3 is down-regulated by S0 and up-regulated by the S2, but not S1
10. S3 is not regulated by S0 and down-regulated by S1, but not S2
11. S3 is not regulated by S0 and up-regulated by S2, but not S1
12. S3 is down-regulated by S0 and up-regulated by both
13. S3 is not regulated by S0 and up-regulated by both
14. S3 is not regulated by S0 and down-regulated by both
15. S3 is down-regulated by S0 and not regulated by either
16. S3 is not regulated by S0 and not regulated by either
Classes 3 and 16 look liek they have the same response scheme. However in class 3 S3
shows no response to its knock-down, but in class 16 S3.
Contrary to the CNO, B-NEM uses indirect measurements (E-genes). E-genes can
be positively or negatively regulated by S-genes. Therefore the equivalence classes are
not minimal anymore. For instance an E-gene E which is positively regulated by S3 in
class 1 (S3 ! E) fits perfectly to class 6, because there it is assumed to be negatively
regulated (S3aE). This is due to the fact that S3jclass 1 = : S3jclass 6. This equivalence
can be resolved with knock-downs during control. If class 1 is correct, the E-gene shows
no eﬀect in the contrast (Control) vs (S3 ). If class 6 is correct, it is up-regulated (> 0).
We have not tackled the general case, but a simple example with two regulatory
parents. This example can trivially be scaled up to n parents. However it becomes
obvious, that an a priori set of experiments to minimalise equivalence classes is not
always feasible. Thus in the next section we describe an alternative approach.
Iterative (a posteriori) set of experiments
Szczurek et al. (2009) have introduced the concept of informative experiments to identify
redundant experiments. Basically if two diﬀerent experiments provide the same informa-
tion, one is redundant and can be omitted. We use the concept of informative experiments
to identify those which resolve equivalence classes.
We start with standard experiments with single knock-downs. We use B-NEM to
identify high scoring but equivalent networks. For these networks we generate simulated
data, including combinatorial perturbations. From the simulated data we deduce the
minimal set of additional experiments to resolve equivalences between networks. Three
toy examples are shown in figure 4.10. The example in figure 4.10a shows the worst case. If
S4 is not down-regulated by any single knock-down, we derive seven equivalent networks
after the first evaluation with B-NEM. Furthermore three networks have minimal size
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(a) A PKN (A) and equivalent networks with minimal size (1-3) and greater size (4-7), given
single knock-downs combined with the stimulation of S0. The networks are equivalent because
S4 is not down-regulated by any single knock-down. We can down-regulate S4 with one of the
three double knock-down in networks 1-3 and two double knock-downs in 4-6. If none of the
three double knock-downs regulate S4, we infer network 7.
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(b) A PKN (A) and two equivalent networks (1-2).
The smaller network (1) is preferred. The equivalence
comes from the fact, that S4 is only down-regulated
by the knock-down of S1. A double knock-down of
S-genes S2 and S3 resolves the equivalence. If S4 is
down-regulated by the double knock-down, we infer
the 2nd network. If it is not down-regulated, we infer
the 1st.
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(c) A PKN (A) and one highest
scoring network (1). In this case
no additional experiments are nec-
essary, since S4 is down-regulated
by both single knock-downs of S1
and S2, but not S3. Combina-
torial knock-downs do not provide
additional information.
Figure 4.10: Iterative experimental design. Three examples for an iterative approach
to experimental designs. Shown are the PKN and highest scoring networks.
and therefore receive the exact same score. Pairwise double knock-downs are necessary
to resolve the equivalences. In the example of figure 4.10b S4 is down-regulated by the
S1 knock-down and we only need one additional double knock-down of S2 and S3. In
the best case scenario in figure 4.10c we do not need any additional experiments. S4
is down-regulated by the two single knock-downs of S1 and S2. Thus it would also be
down-regulated by all combinatorial knock-downs.
Equivalence due to lack of regulated E-genes
Another aspect which can increases the equivalence classes for B-NEMs is the distribu-
tion of E-genes. Let’s assume we have the sequential network in figure 4.11 as a GTN
and no PKN restriction on the search space. Let’s further assume no E-genes are directly
regulated by S-gene S2. We cannot resolve the GTN, because we have E-genes reacting
only to the knock-down of S1 and E-genes, which react to all three knock-downs (ERS,
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Figure 4.11: Missing E-genes. A GTN (left) and its ERS (right).
figure 4.11). That implies that S1 is upstream of S2 and S3. The co-regulated E-genes
do not allow for inference on the order of S2 and S3. However, if we have E-genes directly
regulated by S2, they are independent of S3. Thus S2 is placed upstream of S3. This
has previously been discussed for original NEMs Markowetz et al. (2005, 2007)) and
HM-NEMs (Wang et al. (2014)).
4.3.2 Search Algorithms
B-NEM faces a similar computational challenge as the CNO of Saez-Rodriguez et al.
(2009). However B-NEM is usually applied to much larger datasets and the of E-gene
topology  has to be estimated aswell. Thus we implement a modified version of the GA
to optimize the model.
Our modifications to the GA include complementary insertion (Louis & Rawlins
(1992)), a tournament selection (TS) and non-linear fitness in the SUS. Section 3.3.1
contains details.
(Boolean) Greedy Neighbourhood Search
Besides the genetic algorithm, we also employ a greedy neighbourhood search (GNS)
(Cormen et al. (2007)).
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Algorithm 6 greedy neighbourhood search
1. start with initial network (e.g. random, empty set or fully connected)
2. every edge is evaluated:
(a) if the current network does not contain the edge, it is added and the new
network is scored
(b) if the current network contains the edge, it is deleted and the new network is
scored
3. the edge with the highest score change is then added respectively deleted
4. if there is no improvement stop, otherwise return to step 2
The GNS can be embarrassingly parallelized, since the edge evaluations in step 2 are
independent of each other and can be computed simultaneously on N threads, where N
is the number of edges.
While this is a fast algorithm, it has one drawback. The search space is not always
smooth, but can be contaminated with local optima. The GNS cannot break out of such
an optimum. Therefore the greedy search has to be started several times with diﬀerent
initial networks. This increases the probability to find the global optimum. For example
lets assume the GTN is
fC = A;D = B;E = C ^Dg :
Let’s further assume our starting network is
fC = A;D = B;E = Cg :
The edge E = C ^ D does not change the Boolean logic due to edge E = C and the
absorption law.
E = C _ (C ^D) = C:
Thus it does not improve the score. If the greedy algorithm is changed to inspect pairs
of edges, this can be resolved. Still there are examples, which demand the inspection of
triples and more. Thus we use features of the Boolean functions to more intelligently
traverse the search space.
We introduce a third absorption operation (4.8). Instead of removing the clauses
which include other clauses (normal absorption), the clauses which are included in other
clauses are removed.
Inverse absorption:
x _ (x ^ y)! (x ^ y)
(x ^ y) _ y ! (x ^ y) : (4.8)
The improved GNS is called Boolean Greedy Neighbourhood Search (BGNS).
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Algorithm 7 Boolean greedy neighbourhood search
1. start with initial network (e.g. random, empty set or fully connected)
2. every edge is evaluated under the inverse absorption law:
(a) if the current network does not contain the edge, it is added, inverse absorption
is applied and the new network is scored
(b) if the current network contains the edge, it is deleted and the new network is
scored
3. the edge with the highest score change is then either added (inverse absorption is
applied) or deleted to get the new network
4. if there is no improvement stop, otherwise return to step 2
The BGNS can resolve the GTN from the previous example. It adds E = C ^ D,
simultaneously deletes E = C and scores the new network. In a second example we
assume the GTN to be
fC = A ^B;D = Cg :
Let’s further assume we start with the network
fD = A ^Bg :
The BGNS can hypothetically resolve the GTN the following way:
1. add C = A ^B
2. add D = A ^B ^ C (inverse absorption law: delete edge D = A ^B)
3. add edge C = D (absorption law: delete edge D = A ^B ^ C)
4. stop
The GNS algorithm already stops after step 1.
4.4 Nested Eﬀects Models as restricted Boolean Net-
works
Markowetz et al. (2005) already suggested a logical extension of NEMs. Following this
notion, we interpret original NEMs as special cases of Boolean graphs.
Let G = (V;E) be the graph of a NEM. A vertice v 2 V is 1, if the corresponding
protein is inactive. Thus a knock-down of v means v = 1. In other words the knock-down
has an eﬀect on v. NEM restrict the edges to OR-gates such as v = (v1 _ : : : _ vn).
Therefore a knock-down of any parent has an eﬀect on v and v = 1. The corresponding
protein is modelled as inactive.
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Figure 4.12: NEM and B-NEM graphs. Both networks describe the same pathway.
The extended NEM (1) models inactive proteins respectively knock-downs as 1. The
simplest way to deactivate S5 = 1 through its parents is with a knock-down of S4 = 1.
B-NEM (2) models the active state of a protein respectively a knock-in with 1. The
simplest way to activate S5 = 1 is to activate S2 = 1 and S4 = 1. Due to the property
of the dual form (2.1), we can use the deduction from the NEM graph for the B-NEM
graph. Thus if we knock down S4 = 0, we deactivate S5 = 0.
B-NEM uses the same Boolean network methodology as Saez-Rodriguez et al. (2009).
Thus a knock-down of the protein v is modelled with v = 0. We can interpret the OR-gate
in the NEM case, as an AND-gate in the B-NEM case. For example the NEM OR-gate
C = A _ B is the B-NEM AND-gate C = A ^ B. If we knock down A, it results in a
knock-down of C. In the NEM case the knock-down eﬀect (1) is propagated by A to C
via the OR-gate. In the B-NEM case the inactivation of A (0) prevents the AND-gate
from propagating the signal to C.
NEM: C = A _B = 1 _B = 1:
B-NEM: C = A ^B = 0 ^B = 0:
In general Boolean functions in NEM are the dual forms of the corresponding B-NEM
functions.
We further extend NEM by adding the AND-logic and negation (Vaske et al. (2009)).
For example C = A ^ B means, the protein C is active (C = 0), if we only knock down
A or B (1). If we knock down the combination of both, C becomes inactive (1).
In the example of figure 4.12 we start with a graph on the left representing a Nested
Eﬀects Model, which we can write as the DNF in (4.9).
S5 = (:S1 ^ S2) _ (S2 ^ S3) _ S4 (4.9)
We can transform the dual form from its CNF (4.9) into its DNF (4.10) with Boolean
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algebra (section 2.1).
S5 = (:S1 _ S2) ^ (S2 _ S3) ^ S4
(2.17)z}|{
= ((:S1 ^ S2) _ (:S1 ^ S3) _ (S2 ^ S2) _ (S2 ^ S3)) ^ S4
(2.17)z}|{
= (:S1 ^ S2 ^ S4) _ (:S1 ^ S3 ^ S4) _ (S2 ^ S2 ^ S4) _ (S2 ^ S3 ^ S4)
(2.12)z}|{
= (:S1 ^ S2 ^ S4) _ (:S1 ^ S3 ^ S4) _ (S2 ^ S4) _ (S2 ^ S3 ^ S4)
(2.18)z}|{
= (:S1 ^ S3 ^ S4) _ (S2 ^ S4) :
(4.10)
The extend NEM graph is more helpful to answer the question “how can I deactivate
a S-gene by deactivating a subset of its parents?”. The B-NEM graph is more helpful to
answer “how can I activate a S-gene by activating a subset of its parents?”.
4.5 A Bayesian Networks view on Boolean Networks
Like NEM, we can interpret an unperturbed Boolean acyclic graph (BAG) as a Bayesian
network (3.1, Zeller et al. (2009)). Given a Boolean hyper-graph 	 = (S;H) every S-gene
Si 2 S is independent from its non-descendants, all S-genes not downstream of Si, given
its parents pa(Si;	) in the hyper-graph. The conditional probabilities are calculated by
the Boolean functions (equations (4.11)):
Si =
m_
j=1
0@n(j)^
k=1
Sk(j)
1A
P (Si = s 2 f0; 1g j pa(Si;	)) =
(1  s) 
m_
j=1
0@n(j)^
k=1
Sk(j)
1A :
(4.11)
Figure 4.13 shows an example of a BG and a reduction to a PDAG with the following
joint probability distribution
P (A = a;B = b; C = c;D = d;E = e)
= P (A = a)  P (B = b)  P (C = c jB = b)  P (D = d jA = a; C = c)
 P (E = e jC = c;D = d)
(4.11)z}|{
= a  b  j(1  c)  bj  j(1  d)  (a ^ b)j  j(1  e)  (:c _ :d)j : (4.12)
If the Boolean graph is not perturbed, B and C hold the same values and we cannot
derive the edge direction (causal eﬀect Pearl (2000)). The following equation holds:
P (C = c jB = b)  P (B = b) =
= j(1  c)  bj  b
b=cz}|{
= j(1  b)  cj  c
= P (B = b jC = c)  P (C = c) : (4.13)
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AB
C
D
E
AND
A
B
C
D
E
Figure 4.13: PDAG of a BG. Example of a BG and its corresponding simplification to
a PDAG. Since the PDAG does not explicitly state the Boolean functions defined on the
edges, it represent several diﬀerent BGs.
If C or B is perturbed, they become independent of all other S-genes. If the state of B
does not change during a perturbation of C we infer the edge B ! C, otherwise C ! B.
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5Simulation study
Parts of this chapter have been published (Pirkl et al. (2016)).
Before applying B-NEM in practice we check whether the algorithm can reconstruct net-
works accurately, if the data is generated from known Boolean networks. We refer to
underlying data generating networks as Ground Truth Networks (GTN). The experi-
mental conditions consist of controls, single and double stimulations, single knock-downs
and the single/double stimulations together with single knock-downs. Finally, observed
response schemes were composed by the diﬀerences between controls and single/double
stimulations/knock-downs and the diﬀerences between single/double stimulation and sin-
gle/double stimulation with a single knock-down.
5.1 Principle simulations
GTNs and matching PKNs are generated by randomly sampling edges from a super PKN
shown in figure 5.1. The super PKN has 30 nodes and 144 edges respectively 504 hyper-
edges after extension. The nodes fall onto five layers representing ligands, receptors,
membrane complexes, cytosolic and nuclear signalling. Edges connect nodes on adjacent
layers. 90% of edges are stimulating and 10% are inhibiting. We first draw a PKN and
then a GTN. To generate a network of n nodes we randomly choose n nodes from the
super PKN, ensuring that their is at least one node at every layer. For this set of n
nodes we take all hyper-edges connecting those nodes as the extended PKN. From this
PKN we randomly sample 50% hyper-edges, but make sure that the network is at one
point stimulated. This means we reject GTNs which do not change their state during any
stimulation. Similarly we generate networks of n hyper-edges. Without restricting the
GTN to a specific number of nodes. Finally 10 E-genes are attached to every S-gene. Note
that the PKN is always consistent with the GTN, no existing edges are a priori excluded.
For a given GTN and a set of conditions we calculate the expected E-gene states and
add noise by randomly flipping x% of the values with x 2 f10; 25; 50g. This results in a
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discrete data set. But since in real applications discretization of the data is not always
trivial, we also simulate a continuous data set by adding Gaussian noise  N (0; ) with
 2 f0:5; 1; 2g. Every E-gene profile is generated in triplicates with independent noise.
The algorithm’s eﬃciency is scored on simulated data using the runtime, sensitivity and
specificity (Loong (2003); Deonier et al. (2005))
sens =
TP
TP + FN
; spec =
TN
TN + FP
with TP, TN, FP, TN as the true positive, true negative, false positive and false negative
rates of the hyper-edges. All simulations were performed on a machine with 12 Intel(R)
Xeon(R) CPU X5650 @ 2.67GHz each with 12 megabytes of L1 cache.
For the search algorithm we used
5.1.1 B-NEM accurately estimate the equivalence class of net-
works with up to 30 S-genes.
We first tested the performance of B-NEM for GTNs with 10; 15; 20; 25 and 30 S-genes.
For each size we generated 10 random GTNs and matching PKNs and run B-NEM on
E-gene data generated from these GTNs. The GTNs consisted of 10% of the allowed
edges in the corresponding PKN, hence the PKNs were consistent with the GTN and
eﬀectively reduce the search space. We then compared the expected response schemes
of the estimated networks with that of the GTNs. The top row of figure 5.2 shows the
sensitivity and specificity of the estimated networks (solid circle, dashed triangle). The
corresponding computation time is shown as the dotted line connecting crosses. In this
setting computation is a limiting factor for networks with 30 genes, but reconstruction
accuracy is not.
5.1.2 Network reconstruction is sensitive to the strength of the
prior knowledge network.
In the previous simulation we checked whether the algorithm finds the correct equivalence
class of networks. However, equivalence classes can be large and are hard to interpret.
Due to score equivalence multiple networks in the same equivalence class can not be
distinguished by data. However, equivalence classes can be shrunk eﬀectively by strong
PKNs rendering network reconstruction practical. Thus, we evaluated the accuracy of
the estimated networks as a function of the strength of the PKN. For 10 random GTNs
with 50 hyper-edges drawn randomly from the full PKN, we run B-NEM using PKNs of
50; 164; 277; 390; 504 a priori possible hyper-edges. The bottom row of figure 5.2 shows
the sensitivity and specificity of the reconstructed networks both on the level of expected
response schemes and the actual networks in hyper-edges . While the performance stays
very good with respect to response schemes (equivalence classes) it breaks down with
respect to network reconstruction if the PKN becomes weak.
If we do not allow for negative regulation, the PKN needn’t be a DAG but can have
cycles. Cycles in a PKN with negative regulation can lead to undefined expected response
schemes. See section A.2 for details. Nevertheless we did the same simulations as above
based on a cyclic prior without and with negative regulation (figures D.2 and D.3). Results
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S1
I11 I12 I13 I14 I15 I16
S2 S3 S4 S5 S6
I21 I22 I23 I24 I25 I26
I31 I32 I33 I34 I35 I36
I41 I42 I43 I44 I45 I46
Figure 5.1: DAG as PKN. Example of a randomly created Super-PKN with 30 nodes
and 144 edges in a normal acyclic graph. S1 to S6 are nodes which can be set to 0 or
1 as possible stimulations. A node denoted with I can be inhibited and if not is set by
the states of its parents. Each edge has a 10% chance of being inhibiting. Extending this
PKN with AND gates of size 2 leads to a hyper-graph with 504 hyper-edges.
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Figure 5.2: Simulation results. The three columns show diﬀerent discrete noise levels
f0:1; 0:25; 0:5g. Top: Random GTN of n nodes (x-axis) and the median sensitivity,
specificity of the ERS (solid circle, dashed triangle) and running time (dotted cross) for
ten runs. The top axis shows the mean PKN size. Bottom: Results for ten runs each given
a fixed GTN and diﬀerent PKN sizes (x-axis) including the GTN. Median sensitivity and
specificity of the ERS (solid circle, dashed triangle) and the hyper-edges (dashed-dotted
x, dotted cross).
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Figure 5.3: CNO: GA vs BGNS. Left: Distribution of time consumption. BGNS ran
first. GA was allowed as much time as the BGNS with empty set needed for each run.
Center: Distribution of the minimal score. Right: Distribution of ERS accuracy.
are shown in figures D.4-D.7. While the results with only positive regulation don’t diﬀer
much from the results for DAGs, including negative regulation leads to a decrease in
sensitivity.
5.2 GA vs BGNS
The scoring of each network takes more time in the B-NEM approach compared to the
original CNO (Saez-Rodriguez et al. (2009), Terfve & Saez-Rodriguez (2012), Terfve et al.
(2012)) for several reasons. First of all in B-NEM we have several indirect measurements
(E-genes) instead of just the perturbed proteins (S-genes). Hence the dataset is usually
larger. Additionally B-NEM has to estimate the E-gene positions . Thus in the CNO
setting the GA is already very fast. If the inverse absorption takes longer than scoring
a network the BGNS looses its performance advantage. Therefore we compare the GA1
and the BGNS in the context of the CNO.
We use the PKN from the fundamental simulations in figure D.3. We generate data
the same way as before, except that we only have one E-gene (=S-gene) for each S-gene.
In an initial simulation run the BGNS ran first and the GA was allowed as much time
as the BGNS needed before. In a second simulation run the GA was allowed up to ten
times the amount of time of the BGNS.
Figure 5.3 shows the results. The BGNS gets a better score and also a much higher
accuracy. If we allow the GA to run up to ten times as long as the BGNS, it achieves
similar results (figure 5.4).
1population size 100, maximum stall generations 100, elitism 10% and a fully connected network as
initialization; empty set has similar results
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6The Role of Pi3k and Tak1 in BCR signalling of Burkitt’s
Lymphoma Celline BL2
The results of this chapter have been published (Pirkl et al. (2016)).
6.1 BCR signalling
We now apply the B-NEM framework to a previously unpublished dataset monitoring
gene expression changes in the Burkitt lymphoma cell line BL2 after induction of the BCR.
Our analysis explains how BCR signalling propagates to downstream eﬀector pathways
like the NFB, MAP kinase, P38, or JNK pathways through activation of the intermediate
messengers TAK1 and PI3K.
B-cell receptor signalling was induced in BL2 cells by cross-linking IgM with an anti-
IgM antibody. S-genes were inhibited on protein level using small molecules: 5Z-7-
oxozeaenol (TAK1), IKK2 inhibitor VIII (IKK2), Ly294002 (PI3K), SB203580 (P38/MAPK14),
SP600125 (JNK), U0126 (ERK1/2). In addition to single inhibitions, IKK2, JNK and
P38 were jointly inhibited yielding three double and one triple inhibition. All perturba-
tions were done in triplicate both under BCR stimulation and control conditions and gene
expression profiles were generated using Aﬀymetrix hgu133plus2 Genechips. Moreover,
profiles of 6 negative controls (unstimulated BL2 cells) and 6 positive controls (BCR
stimulated cells) were produced, yielding a dataset of 72 gene expression profiles in total.
The dataset was made available at the GEO database1 under accession id GSE68761.
6.2 Gene expression profiling and preprocessing
The BCR data set was generated using Aﬀymetrix GeneChip Human Genome U133 Plus
2.0 arrays. Profiles were normalized on probe level using the variance stabilization method
of (Huber et al. (2002)). Batch eﬀects were corrected using ComBat (Johnson et al.
1http://www.ncbi.nlm.nih.gov/geo/
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(2007)). The foldchanges used in the B-NEM modelling were calculated with the limma
package 3.16.1 (Smyth (2004)). The following contrasts were calculated: “Stimulation
- Control” (stimulation eﬀect), “Inhibition_Stimulation - Stimulation” (silencing of the
stimulation during knock-down). See also table 6.1. We calculated general coeﬃcients ij
for each gene i and variable (experimental condition) to calculate the gene expression yi.
yi = 0  Ctrl+1  BCR+2  Jnk+3  p38+4  Ikk2+5  Pi3k+
6  Tak1+7  BCR&Jnk+8  BCR&p38+9  BCR&Ikk2+
10  BCR&Pi3k+11  BCR&Tak1+i (6.1)
with a small error i. Last we removed “AFFY” control probesets from the data. The
aﬀymetrix probeset ids were converted to HGNC gene symbols (Gray et al. (2015)) with
the hgu133plus2.db, annotate and biomart R packages (Carlson (n.d.); Gentleman (n.d.);
Smedley et al. (2015); R Core Team (2014)). After the raw data was normalized, observed
response schemes were calculated for the comparisons listed in table 6.1. We filtered for
E-genes that respond to BCR stimulation by at least an absolute log2 foldchange of 1
and to another comparison by at least an absolute log2 foldchange of log2(1:5)  0:58.
This corresponds to a change in expression of at least 100% respectively 50%, leaving us
with 602 E-genes.
base level change level
(control) vs (BCR+)
(BCR+) vs (BCR+,PI3K-)
(BCR+) vs (BCR+,TAK1-)
(BCR+) vs (BCR+,ERK-)
(BCR+) vs (BCR+,IKK2-)
(BCR+) vs (BCR+,P38-)
(BCR+) vs (BCR+,JNK-)
(BCR+) vs (BCR+,IKK2-,P38-)
(BCR+) vs (BCR+,IKK2-,JNK-)
(BCR+) vs (BCR+,P38-,JNK-)
(BCR+) vs (BCR+,IKK2-,P38-,JNK-)
Table 6.1: Contrasts. Contrasts of conditions used to calculate the observed response
schemes from the data. + denotes activation of the node and   inhibition in that par-
ticular condition.
6.3 Results
6.3.1 Prior knowledge in BCR signalling
The B-cell receptor (BCR) is the cell surface receptor that initiates BCR signalling upon
binding of an antigen. BCR signalling leads to the activation of IKK2, P38, ERK, and
JNK (DeFranco (1997); Richards et al. (2001); Schuman et al. (2009); Shinohara &
Kurosaki (2009)). These four eﬀector pathways send signals into the nucleus that aﬀect
gene expression. The two proteins PI3K and TAK1 are potential mediators of BCR
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induced activation of eﬀector pathways. We do not put any restriction on the hierarchical
ordering of PI3K and TAK1. PI3K and TAK1 are parts of several other pathways where
they are described as activators and not as repressor of signalling. We thus assume that
the same holds true in BCR induced signalling. What is not known is which activations
depend on which of the two mediators, nor is it known whether they activate downstream
pathways independently from each other (OR gate) or jointly (AND gate). Furthermore
the combinatorial inhibitions of IKK2, P38 and JNK allow more freedom in the PKN
and therefore we do a complete reconstruction on this subnetwork. We summarize this
prior knowledge situation in the PKN of Figure 6.1.
6.3.2 Calibrating the sparseness parameter 
BCR
PI3K
TAK1
IKK2
P38
JNK
ERK
Figure 6.1: Prior search space restric-
tion. PKN for BCR signalling into IKK2,
P38, JNK and Erk. We do not allow for
negative regulation. Naturally, BCR defines
the top S-gene. PI3K and TAK1 build the
second hierarchical layer but we addition-
ally allow for TAK1 above PI3K or the re-
verse. The third layer consists of IKK2, P38,
JNK and ERK. Since our combinatorial in-
hibitions reduce the problem of equivalence
classes for IKK2, P38 and JNK we allow for
the complete reconstruction of the sub net-
work consisting of these three S-genes.
Calibrating  is critical to the perfor-
mance of B-NEM. We randomly split the
set of E-genes in half. For various set-
tings of  (exponential decrease  2
f1; 0:64; 0:36; 0:16; 0:04; 10 10; 0g) we learn
a network using the first half of the data
(training set), and then score this network
using the second independent half (test
set) but without employing the complex-
ity penalty in equation (4.1). We repeat
this step with 100 diﬀerent random splits
of E-genes and take the mean of graph size,
connected S-genes (both in percent) and
scores of the test sets. Figure 6.2 shows
that the score continuously improves as 
approaches zero. For  = 0 the test accu-
racy drops again. Note that for any posi-
tive zeta the smaller network wins in case
of likelihood equivalence while for  = 0
there is no size penalty operating at all.
We thus set  to 10 10.
6.3.3 The role of PI3K and
TAK1
We run B-NEM on this data using the
PKN and the parameter settings described
above. Figure 6.3 shows the highest scoring network. The network predicts that the acti-
vation of the JNK pathway is only PI3K dependent, while Erk is only TAK1 dependent.
IKK2 activation is predicted either as redundant by PI3K or alternatively TAK1. P38 is
positively regulated by PI3K via either JNK or alternatively jointly with IKK2. The sig-
nal flow to P38 can be stopped either with the inhibition of PI3K or the double inhibition
of JNK and IKK2. The observed response schemes side by side with the corresponding
expected response schemes can be seen in figures 6.5-6.11 .
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Figure 6.2:  calibration. Mean cross validated network scores as a function of the
complexity parameter . Score on the test dataset (solid circle, log-scale) and graph size
in percent (dashed triangle).
BCR
ERK
IKK2
JNK
P38
PI3KTAK1
Transcription
AND
Figure 6.3: Learned network. The highest scoring network (black edges). The BCR
signal is propagated via PI3K into JNK and P38. IKK2 is alternatively regulated by
PI3K or TAK1. PI3K and TAK1 are directly regulated by BCR. TAK1 propagates the
signal into the ERK pathway. Additionally P38 is alternatively regulated by JNK or
IKK2. The diﬀerent AND and OR gates are annotated more prominently. Grey dashed
edges illustrate the propagation of signals from all molecules into the nucleus to regulate
transcription.
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Figure 6.4: Inference on BCR signalling with the original NEM.
That TAK1 alone, as proposed by our model, can not block signalling into IKK2 and
JNK has been detected for toll-like receptor 8 (TLR8) signalling in mouse embryonic
fibroblasts (MEF, Qin et al. (2006)). TAK1 knock-out mice still showed an activated
NFB pathway. TLR8 also seems to be causative in some lymphomas (Ngo Vu N. et al.
(2011)). Furthermore Matta et al. (2012) show that herpes virus encoded viral FLICE
inhibitory protein (vFLIP) K13 inducted NFB activity is not impaired in TAK1 deficient
MEFs. Chen & Debnath (2013) give evidence that the IKK complex (IKK1, IKK2,
NEMO) acts independently of PI3K in mammary epithelial cells and Xue et al. (2000)
that ERK can be activated independently from PI3K in nerve growth factor (NGF)-
dependent sympathetic neurons. Kloo et al. (2011) propose the regulation of IKK2 by
PI3K in diﬀuse large B-Cell like lymphomas. They show in their data, that the PI3K
inhibitor only partially blocks IKK2 inhibitor target genes I.e. downstream targets of
PI3K are a subset of downstream targets of IKK2, which is not true in our case. In the
Nested Eﬀects Model logic this either places PI3K downstream of IKK2 or PI3K and
IKK2 have joint downstream targets. A third explanation is, that some NFB activity
is regulated by PI3K, but another alternative regulation is possible as depicted in our
network in figure 6.3.
For comparison we used standard Nested Eﬀects Models (Markowetz et al. , 2005;
Froehlich et al. , 2008) to model the BCR data set. Since NEM uses only single per-
turbations, we discarded all combinatorial perturbations. We discretized the foldchanges
using log2(1:5) as cutoﬀ. Figure 6.4 shows the result. In disagreement to established
knowledge ERK is placed up stream of all S-genes except PI3K indicating the need to
use both Boolean logic and prior knowledge in modelling BCR signalling.
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response scheme (bottom row) and ob-
served response schemes (top rows).
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Figure 6.6: Top 30 E-genes (= aﬀymetrix
probesets) regulated by ERK directly. Ex-
pected response scheme (bottom row) and
observed response schemes (top rows).
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Figure 6.7: Top 30 E-genes (= aﬀymetrix
probesets) regulated by IKK2 directly. Ex-
pected response scheme (bottom row) and
observed response schemes (top rows).
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Figure 6.8: Top 30 E-genes (= aﬀymetrix
probesets) regulated by JNK directly. Ex-
pected response scheme (bottom row) and
observed response schemes (top rows).
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Figure 6.9: E-genes (= aﬀymetrix probe-
sets) regulated by P38 directly. Expected
response scheme (bottom row) and ob-
served response schemes (top rows).
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Figure 6.10: Top 30 E-genes (= aﬀymetrix
probesets) regulated by PI3K directly. Ex-
pected response scheme (bottom row) and
observed response schemes (top rows).
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Figure 6.11: E-gene (= aﬀymetrix probeset)
regulated by TAK1 directly. Expected re-
sponse scheme (bottom row) and observed
response schemes (top rows).
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7Analyzing Crosstalk of Inflammatory and Apoptotic Signalling in
Hepatocellular Carcinoma
7.1 Hepatocellular Carcinoma
Liver cancer (hepatocellular carcinoma, HCC) is one of the most common forms of cancers
world wide and has a high mortality rate. The largest risk factors leading to carcino-
genesis are hepatitis B and C viruses. Other attributing factors include smoking, alcohol
consumption and exposure to aflatoxin B1 (Gomaa Asmaa Ibrahim et al. (2008)).
Important pathways are often de-regulated in HCC (Dufour & Clavien (2005)). For
example in some cases NfB is constitutively active. NfB signalling has anti-apoptotic
eﬀects, like the inhibition of Casp8. This leads to a constant survival signal and helps
cancer cells to avoid apoptosis. Thus the cancer can grow and proliferate.
7.1.1 Tnf- and Trail signalling in HCC
Tumor Necrosis Factor alpha (Tnf-) is a molecule, which can bind to the receptor Tnfr1
in the cell membrane. Tnf- regulates a wide range of cellular responses like cell death,
proliferation (Bradley (2008)) and in particular the pro-survival pathways regulated by
the proteins Jnk and NfB (Wajant et al. (2003), Silke (2011); Metzig et al. (2011a)).
However many other signalling molecules are involved in the regulation of these pathways
and act as mediators such as the the signalling kinases Tak1 and Nik (Haas et al. (2009);
Walczak (2011); Darding & Meier (2012); de Almagro & Vucic (2012)).
The Tnf- related apoptosis-inducing ligand (Trail, Schaefer et al. (2007)) is a member
of a subfamily of Tnf- related molecules. Trail regulates the extrinsic activation of
apoptosis (Falschlehner et al. (2009)). It binds to one of the death receptors Dr4 or Dr5.
These two propagate the signal to Casp8 which activates Casp3. Then Casp3 degrades
proteins, which leads to cell death.
Many pathways communicate with each other via crosstalk (Zucchini-Pascal et al.
(2013); Imai et al. (2014)). Tnf- and Trail are not isolated pathways either. Both path-
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ways share many signalling molecules with each other (Kim et al. (2002); Falschlehner
et al. (2007); Jouan-Lanhouet et al. (2012); Azijli et al. (2013)). For example they are
both known to regulate Casp8 activity.
Several previously unknown molecules have been identified to be involved in Tnf-
or Trail signalling. Among those are Usp2 (Metzig et al. (2011b); Mahul-Mellier Anne-
Laure et al. (2011)), Casp4 (Mao et al. (2010); Nickles et al. (2012)) and Casp8ap2
(Imai et al. (1999); Choi et al. (2001); Jun et al. (2005); Hummon et al. (2012)).
Sharpin, Hoip and Hoil1 form the linear ubiquitin chain assembly complex (LUBAC) and
are also assumed to mediate Tnf- and Trail induced signals (Walczak (2011)).
In general of importance when it comes to de-regulated cell function and cancer is
the Wingless-Type (WNT) pathway. Not only is this pathway responsible for several
pro-survival responses like cell proliferation and migration, but it has also been shown
to interact with known Tnf- and Trail signalling molecules (Lamberti et al. (2001);
Toyama et al. (2010); Mahmoudi Tokameh et al. (2009); Zimmerman et al. (2013);
Hiyama et al. (2013)). Additionally there is strong evidence, that the WNT signalling
molecule Beta-Catenin (CTNNB1) is mutated in the HCC cell line HepG2, which might
alter normal Tnf- and Trail signalling (Lachenmayer et al. (2012); Kan et al. (2013);
Tornesello et al. (2013)).
Since Trail can induce apoptosis in some and not in other cells, the idea is to kill cancer
cells but keep normal cells alive. Thus we have to identify potential targets to make cancer
cells sensitive and normal cells resistant to Trail induced apoptosis. The WNT pathway
and Tnf- are known to counteract the apoptotic signal. Therefore proteins involved
in the crosstalk of WNT, Tnf- and Trail might help to achieve sensitivity respectively
resistance in certain cell types (Falschlehner et al. (2007); Papenfuss et al. (2008); Russo
et al. (2010)).
7.2 Data generation and processing
Cells were treated for 24 hours with either Renilla luciferase (Rluc, Shifera & Hardin
(2010)), a non-target small interfering RNA (siRNA), both as negative controls, or
siRNAs targeting specific mRNAs. Each mRNA was targeted by a pool of four siR-
NAs to reduce oﬀ-target eﬀects (Jackson & Linsley (2010); Hannus Michael et al.
(2013)). Then the cells were stimulated with Tnf-, Trail or both and sequenced at
time points 0 hours (control, no stimulation), 2 hours and 4 hours. The cells were se-
quenced on SOLID™ 4 and SOLID™ 5500 machines (http://www.appliedbiosystems.
com, Wikipedia (2016a)). The sequences were mapped to the human reference genome
hg19, build 37 with the Bioscope™ v1.3 software. Counts were generated with the HTSeq
python package (Anders et al. (2015)).
The data consists of a gene expression count matrix with 21969 rows (genes) and
1268 columns (samples). The experiments are combinations of stimulations and siRNA
treatments in triplicate. Overall, three diﬀerent stimulations (Tnf-, Trail, Tnf-&Trail)
and 37 genes were targeted. The genes targeted are (hgnc gene symbols, Gray et al.
(2015)):
APC, ATF2, BIRC2 (cIap1), BIRC3 (cIap2), CASP4, CASP8, CFLAR (c-Flip), CHUK
(Ikk1), CTNNB1 (Beta-Catenin), DKK1, DKK4, FLASH, IKBKB (Ikk2), IKBKG (Nemo),
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JUN (cJun), MAP2K1 (Mekk), MAP3K14 (Nik), MAP3K7 (Tak1), MAPK8 (Jnk),
PIK3CA (Pi3k), RBCK1 (Hoil1), RELA, RIPK1 (Rip1), RIPK3 (Rip3), RNF31 (Hiop),
SHARPIN, TAB2, TCF7L2 (Tcf4), TNFRSF10A (Dr4), TNFRSF10B (Dr5), TNFRSF1A
(Tnfr1), TNIK, TRAF2, USP2, WLS (Evi), WNT11, WNT5A.
The brackets hold common protein names. We use protein names or the lower case of
the gene names when we talk about pathways. When we talk about mRNA or siRNA we
use the gene names.
Experimental conditions available are
• control (no stimulation, either no or control siRNA)
• gene knock-down (siRNA)
• stimulation measured at time points 2 hours and 4 hours after stimulation (either
no or control siRNA)
• stimulation in combination with siRNA measured at time points 2 hours and 4
hours after stimulation.
Genes that have a mean raw count expression of less than ten over all samples are not
used in further analysis.
We calculate normalizing factors to account for varying library sizes among samples
with edgeR (Robinson Mark D et al. (2009)). We put the normalized counts into the
Voom pipeline which log normalizes the data and calculates weights for every entry to
account for observational variation. Voom uses a linear model to calculate the weights
(Law et al. (2014), equation (7.1)). Then the normalized expression values and the
weights are put in the Limma pipeline (Smyth (2004)).
yi = 0;i  Ctrl+
X
siRNA
 
siRNA1;i  siRNA

+X
H2f2;4g
 
H1;i  TnfH +H2;i  TrailH +H3;i  Tnf&TrailH +X
siRNA

siRNA;H2;i  siRNA&TnfH+
siRNA;H3;i  siRNA&TrailH + siRNA;H4;i  siRNA&Tnf&TrailH

+ i (7.1)
with the expression yi for gene i, the time point H and a small error i.
We calculate the log foldchanges for each gene based on the contrasts
• stimulation - control =(control) vs (stimulation+)
• siRNA&stimulation - stimulation =(stimulation+) vs (stimulation+,gene-)
• siRNA - control =(control) vs (gene-).
For each gene we consider the two time points as two diﬀerent genes. For example the
gene ICAM1 has the above contrasts, except for siRNA - control, for time point two
hours and time point four hours. We account for this by introducing the two diﬀerent
genes ICAM12h and ICAM14h. Instead of one gene with identical conditions for two time
points, we now have two genes for one time point. From now on we refer to the gene at
two hours simply as ICAM1.
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Figure 7.1: siRNA eﬃciency. On the y-axis is the mRNA and on the x-axis the contrast
siRNA - control. The diagonal indicates the eﬀectiveness of the siRNA knock-down on
its mRNA target.
Gene selection
We define target genes by an absolute log2 foldchange  1 in any stimulation - control
contrast. Additional we demand a diﬀerential regulation by at least log2(1:5)  0:58
with the opposite sign by the receptor during the associated stimulation. For instance
if a gene has a foldchange of  1 in (control) vs (Tnf-+), it must have a foldchange of
  log2(1:5) in (Tnf-+) vs (Tnf-+, Tnfr1 ). These criteria reduce the data set to
1376 genes.
Quality of siRNA
We check the siRNA eﬀectiveness for each targeted mRNA (figure 7.1). However some
targets like IKBKG are not shown, because they had a too low raw expression. Overall
the siRNAs have a high sensitivity, except for CASP8 and MAP3K14.
Including WNT targets
Additionally to the previously selected genes we include genes, which are aﬀected by active
Beta-Catenin signalling. Thus we select genes, which have an absolute log2 foldchange
of  1 in (control) vs (Beta-Catenin ) and an absolute log2 foldchange of  log2(1:5) in
(control) vs (Tcf4 ). We discard genes, which are diﬀerently regulated by both knock-
downs, because we assume positive regulation of Tcf4 by Beta-Catenin (Beta-Catenin !
Tcf4).
316 genes are identified as WNT targets. Among them we find the known WNT
target AXIN2 of two and four hours (Jho et al. (2002)). It is down-regulated by both
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Figure 7.2: WNT target genes. Observed response schemes of WNT target genes
(rows). The weak knock-down eﬀect of Beta-Catenin during Tnf- stimulation is clearly
visible.
the Beta-Catenin and Tcf4 knock-downs.
The WNT regulated genes react to Beta-Catenin and Tcf4 knock-downs during al-
most all stimulations (figure 7.2). However during the single Tnf- stimulation combined
with the Beta-Catenin knock-down, the foldchanges have the correct sign but are visi-
bly weaker. We investigate this eﬀect by using B-NEM to estimate the optimal network
based on the PKN in figure 7.3, A and the ORS in figure 7.2. The optimum is shown in
figure 7.3, B. Beta-Catenin is constitutively active (Beta-Cat. = :FALSE = :0 = 1).
Tnf- can activate Tcf4 independent of Beta-Catenin. Trail inhibits this activation. Thus
during the double stimulation and the single Trail stimulation only Beta-Catenin acti-
vates Tcf4. This confirms the weak knock-down eﬀect of Beta-Catenin during the single
Tnf- stimulation (figure 7.2).
B-NEM cannot resolve, which receptor, Dr4, or Dr5, or both negatively regulate Tcf4.
However combinatorial knock-downs of Dr4, Dr5 and Beta-Catenin would resolve this
uncertainty. For example if only Dr4 inhibits the activation of Tcf4 by Tnf-, the double
knock-down of Dr4 and Beta-Catenin will up-regulate Tcf4 during the double stimulation,
the double knock-down of Dr5 and Beta-Catenin won’t.
7.3 Prior knowledge
We employ the KEGG pathway database (Kanehisa & Goto (2000); Kanehisa et al.
(2014)) to define a PKN for the Trail, Tnf- and WNT pathways (figure D.8). Addition-
ally we place Evi according to Voloshanenko Oksana et al. (2013). We also include the
interactions of the Tnf- and Trail receptors with Tcf4 from the previous section.
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Figure 7.3: WNT model. WNT prior network (A), the estimated optimum (1) and
three equivalent networks (2-4). Blue edges with a diamond head denote ambiguous
regulation (! and a possible).
7.4 Results
7.4.1 The core network
For the following analyses, we use the union (1643) of previously selected genes.
Training 
Before we search for the optimal network for the large Tnf- and Trail pathways, we train
the  parameter. We do this by splitting the dataset in half leaving 821 respectively 822
genes in each. One is the training set and the other is the test set. We then estimate
the optimal network for the training set and a size penalty   0. We score the test
set on the optimal network with  = 0. We do this for several values for  (exponential
decrease  2 f1; 0:64; 0:36; 0:16; 0:04; 10 10; 0g) in 100 repetitions. The results are shown
in figure 7.4. The score for the test set increases until  = 10 10 and decreases again for
 = 0. Thus we set  = 10 10 in further analyses.
Optimal network
The optimal network for Tnf- and Trail is shown in figure 7.5. We identify the following
features:
• Casp8 is activated only by Trail and not Tnf-.
• Active Tnf- makes the activation of Casp8 less robust. If only Trail is stimulated
the signal to Casp8 can only be blocked by Dr5. In the double stimulation the
signal to Casp8 can be blocked by both death receptors Dr4 and Dr5.
• The NFB pathway (RelA) is only activated by Nemo and not Ikk1 and Ikk2.
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Figure 7.4: Training . Mean cross validated network scores as a function of the com-
plexity parameter . Score on the test dataset (solid circle, log-scale) and graph size in
percent (dashed triangle).
• Beta-Catenin is active during control and activates Tcf4, which activates Evi, Wnt11
and Wnt5A, and finally Apc. Apc is inactive during control and active during the
knock-downs of upstream proteins such as Beta-Catenin.
Modified PKN to remove local residuals
Figure 7.6 shows the residuals in the positive residuals matrix (PRM) and the negative
residuals matrix (NRM, section 4.2.10). We marked the interesting residuals in figure 7.6
with blue boxes. We concentrate on two types of residuals: strong eﬀects and systematic
eﬀects. For example residuals for Wnt5a (row) are relatively small, but occur always with
the Nik knock-down. The following list describes how we intend to account for them with
a modified PKN.
• PRM:
1. (control) vs (Trail+): Trail activates multiple S-genes, thus we add edges Dr5,
Dr4 ! S-gene to the PKN.
2. Apc (green): Apc E-genes are up-regulated by the Traf2 but not the Tnfr1
knock-down during Tnf- stimulation. Thus we add edges Traf2 a Apc and
Tnfr1 ! Apc, because without the second edge Tnfr1 would also indirectly
inhibit Apc: Tnfr1 ! Traf2 a Apc.
3. Apc (red): Evi does not inhibit Apc. Thus we add feed forward loops from
Tcf4 to Wnt5a and Wnt11 to bypass Evi.
4. Casp8: the residuals contradict our model but imply an inhibition of Casp8
by Apc, C-Flip and Pik3.
5. Wnt5a: E-genes of Wnt5a are up-regulated by the Nik knock-down, thus we
add a negative edge from Nik to Wnt5a.
• NRM:
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Figure 7.5: Tnf--Trail-WNT result. Estimated network.
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Figure 7.6: Residuals in the Data. Residuals in the observed response scheme for the
optimal network in figure 7.5. PRM (top): Network predicts no eﬀect, but the E-genes
fit better, if one is predicted (green). Network predicts eﬀect, but the E-genes fit better,
if none is predicted (red). The same for negative eﬀects is shown in the NRM (bottom).
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Figure 7.7: Updated Tnf--Trail-WNT result. Relearned network based on
PKN D.9.
1. Casp8: E-genes of Casp8 are down-regulated during knock-downs of Beta-
Catenin, Wnt11 and Rip1. Thus we add edges Beta-Catenin! Casp8, Wnt11
! Casp8, Rip1! Casp8. However Beta-Catenin and Wnt11 are not activated
by the receptors. We account for this with edges Tnfr1, Dr4, Dr5 a Casp8.
2. Wnt5a: E-genes of Wnt5a are down-regulated during the knock-down of Traf2,
thus we add Traf2 ! Wnt5a.
Before we relearn the network based on the new revised PKN (figure D.9), we fix
E-gene positions  in the current optimum, which we also use as start network in the
search. The new optimum (figure 7.7) gets a higher score. However it still has some
residuals (figure D.10). The ones in the positive eﬀects matrix are not resolvable due to
the binary type of our model. For example Casp8 is up-regulated in (control) vs (Trail+)
and up-regulated in (Trail+) vs (Trail+, Pik3-). Thus according to the data Casp8 has
three diﬀerent states instead of just 0 and 1.
As an example E-genes regulated by RelA are shown in figure 7.8.
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Figure 7.8: Top RelA regulated E-genes for the updated result. The bottom row
is the expected response scheme of RelA. The other rows show the observed response
schemes of attached E-genes.
We account for the non-resolvable residuals with additional manual edges (figure 7.9).
We identify the following features:
1. Beta-Catenin is essential for Casp8 activation.
2. Casp8 activation by Trail is less robust during Tnf- stimulation. It can be deac-
tivated by both Trail receptor knock-downs in the double stimulation, but only by
Dr5 knock-down in the single Trail stimulation.
3. The Trail signal to c-Flip cannot be blocked by any knock-down during the single
stimulation. During the double stimulation c-Flip can be blocked by the NfB
pathway (i.e. RelA and Nemo).
4. Evi is activated by Beta-Catenin, but it is no mediator between Beta-Catenin and
other WNT molecules.
5. Traf2 inhibits Apc.
6. c-Flip, Pik3 and Apc inhibit Casp8 during Trail stimulation.
7. Rip3 and Wnt11 activate Casp8 during Trail respectively the double stimulation.
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Figure 7.9: Manually curated network. Sub-graph of the estimated network of fig-
ure 7.7 showing the most important interactions (black and red edges). The green and
pink edges show interactions which cannot be modelled with our binary states, but are
implied by the residuals.
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Figure 7.10: Manually curated network with novel S-genes. Sub-graph of the
estimated network of figure 7.7 showing the most important interactions (black and red
edges). The orange edges visualize associations of novel S-genes with the core network.
7.4.2 Testing unknown S-genes for interaction
We have several S-genes for which we have no prior knowledge. We employ Fisher’s exact
test (Fisher (1922); Agresti (1992)) to infer their position in the network.
Target E-genes of a novel S-gene must fulfill
(control) vs (stimulation+) > 
and
((control) vs (stimulation+))  ((stimulation+) vs (stimulation+; S-gene )) < 0
for any stimulation (Tnf-, Trail, Tnf-&Trail). We set  = log2(1:5)  0:58. For
example if an E-gene is up-regulated by Tnf- stimulation and down regulated by the
knock-down of Hoip during Tnf- stimulation, it is a target of Hoip.
We infer an undirected edge (association) between a S-gene in the network and a novel
S-gene, if there is a significant overlap between their target genes. For significance we use
Fisher’s exact test. P-values are corrected for multiple testing with the false discovery
rate (FDR) of Benjamini & Hochberg (1995). We draw an undirected edge between two
S-genes, if FDR < 10%. The results are shown in figure 7.10 (orange edges).
The left side of the network shows many association with the WNT pathway. These
include not just known WNT molecules (Dkk1, Dkk4), but also previously mostly un-
known relations (Usp2 , Casp8ap2, Casp4, Sharpin (Rivkin Elena et al. (2013)), Tnik
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(Mahmoudi Tokameh et al. (2009))). Casp4 and Casp8ap2 specifically are involved with
many WNT related molecules. Additionally Casp8ap2 is associated with Beta-Catenin
and Casp4 with RelA, but no other RelA regulaters. Hoil1 acts a as a mediator between
Dr5 and Casp8, while the other LUBAC member Hoip is involved in NFB signalling
(Nemo, RelA).
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8Applying B-NEM to time series data
B-NEM can infer networks based on diﬀerent combinatorial experiments: stimulations
(knock-ins), knock-downs, individually and in arbitrary combinations. However combina-
torial knock-downs and knock-ins are not common practice. Much more so are standard
experiments (definition 4.4), especially single stimulations combined with at most single
knock-downs. Those experiments are very restrictive to the power of B-NEM, particularly
for the inference of OR-gates.
In this chapter we show how B-NEM estimates Boolean features, like OR-gates, from
time series data derived from standard perturbation experiments.
8.1 Algorithm
Let us assume we have a standard set of experiments. It consists of a control experiment
without any perturbation, a single stimulation S and experiments with single inhibitions
of pathway members S = fS1; : : : ; Sng during the stimulation. These experiments are
available for several time points t 2 ft1; : : : ; tmg. We assume further that the actual
stimulation of S-genes depends on the time point t. This means, that at every time point
t a certain subset of S is directly stimulated. See figure 8.1 for a triple example.
Algorithm 8 outlines the steps by means of the example in figure 8.1.
Algorithm 8 inference on time series data
1. estimate the network (figure 8.1, C) for each individual time point t (figure 8.1, B)
2. reannotate the conditions according to the results (figure 8.1, D)
3. combine the reannotated samples for all time points to one dataset
4. estimate the network from the combined data
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Figure 8.1: Toy example for algorithm 8. (A) PKN with three knock-down targets
(S1; S2; S3) and the stimulation S. (B) Standard contrasts at time point t. + denotes a
stimulation (knock-in) and   an inhibition (knock-down). (C) Static network estimated
from contrasts of time point t (table A). (D) Reannotated contrasts resolved from time
point t in table B. S1 and S3 have no parents except for S (network C). Thus they are
directly stimulated and we replace St+ in the contrasts with S1+; S3+. In the case of
ambiguity   overrules +. For example (S1+,S3+,S1-) = (S3+,S1-).
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Figure 8.2: Cyclic PKN for time series data. Strictly positive PKN with 5 (A) and
10 (B) S-genes.
As outlined in algorithm 8, we first learn the network for each individual time point.
For a single time point we model an upstream stimulation S. S positively regulates all
other S-genes in the extended PKN (S ! Si, 8.1, A). For example assume at time point
t, S1 and S3 do not have parents except for S (figure 8.1, B). We then reannotate the
samples of this time point as if S1 and S3 are directly stimulated (table 8.1, C). In the
next section we validate this algorithm on simulated data.
8.2 Simulation
8.2.1 Data generation
We start with a cyclic PKN of n 2 f5; 10g S-genes with exclusively positive edges (fig-
ure 8.2). We draw a random cyclic GTN and create observed response schemes analog
to chapter 5. Instead of the standard experiments, every S-gene can be stimulated or in-
hibited. Then we simulate up to double stimulations combined with single knock-downs.
The resulting contrasts for a triple of S-genes are shown in table 8.1.
We define time points from the full dataset. A time point is defined as a subset of stim-
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all contrasts time point X time point Y
base level change level base level change level base level change level
(control) vs (S1+) (control) vs (S1+) (control) vs (S1+,S2+)
(control) vs (S2+) (S1+) vs (S1+,S2-) (S1+,S2+) vs (S1+,S2+,S3-)
(control) vs (S3+) (S1+) vs (S1+,S3-)
(control) vs (S1+,S2+)
(control) vs (S1+,S3+)
(control) vs (S2+,S3+)
(S1+) vs (S1+,S2-)
(S1+) vs (S1+,S3-)
(S2+) vs (S2+,S1-)
(S2+) vs (S2+,S3-)
(S3+) vs (S3+,S1-)
(S3+) vs (S3+,S2-)
(S1+,S2+) vs (S1+,S2+,S3-)
(S1+,S3+) vs (S1+,S3+,S2-)
(S2+,S3+) vs (S2+,S3+,S1-)
Table 8.1: Contrasts from a cyclic Boolean network. Left: Contrasts of conditions
used to calculate the expected and observed response schemes for a positive cyclic Net-
work. + denotes a stimulation (knock-in) and   an inhibition (knock-down). Center and
Right: Two subsets or “time points X and Y” of the contrasts.
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Figure 8.3: B-NEM simulation results. Plots for five respectively ten S-genes. Dashed
lines show ten random time points and solid lines show five (five S-genes) and 20 (ten
S-genes). Black lines show the median balanced accuracy of the ERS and red lines the
median balanced accuracy of the hyper-edges. Discrete noise levels are 0:1; 0:25; 0:5 and
continuous noise levels are from a Gaussian distribution  N (0; ) with  2 f0:5; 1; 2g.
ulated S-genes with the corresponding knock-down conditions (table 8.1, center/right).
This results in 
n
1

+

n
2

= m 2 f15; 55g
diﬀerent time points for n = 5 respectively n = 10 S-genes.
8.2.2 Results
We estimate the network for a random subset of five, ten and twenty time points each
using algorithm 8. The results over ten independent runs are shown in figure 8.3.
B-NEM reaches a high median balanced accuracy (= sensitivity+specificity
2
) for the
ERS and for the hyper-edges for five S-genes. For ten S-genes the accuracy for the
ERS remains high, while the accuracy for the hyper-edges drops down. Additionally the
simulations show that more time points lead to higher accuracy.
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Figure 8.4: Simulated stimulation signal. Example of ten E-genes in the data set of
Ivanova et al. (2006) preprocessed by Anchang et al. (2009). Green are the discretized
eﬀects (+1) for every knock-down. Red is our in silico added stimulation eﬀect ( 1)
between positive (S) and negative control. Probe sets 1416246_a_at and 1448154_at
have a standard deviation of 0 without the contrast “(control) vs (S+)”.
8.3 Self renewal in embryonic stem cells
Ivanova et al. (2006) produced gene expression data from experiments with knock-downs
by short hairpin RNA (shRNA; Taxman et al. (2010)). They target six genes involved
in the self renewal of mouse embryonic stem cells: Nanog, Sox2, Oct4, Tbx3, Esrbb and
Tcl1 (S-genes). The gene expression for each knock-down is measured at eight diﬀerent
time points with microarrays.
Before we make inference on the time series we compare B-NEM to other NEM ex-
tensions (Anchang et al. (2009), Froehlich et al. (2011), Sadeh et al. (2013)). We
use the last time point of 122 genes as previously described in Anchang et al. (2009)
for network reconstruction. The preprocessed data is available in the R package “nem”
(Froehlich et al. (n.d.)). However there is no “(control) vs (stimulation+)” contrast in
the preprocessed data and since the data is discretized our correlation measure could
fail. For example E-genes 1416246_a_at and 1448154_at have a constant value of 1 in
their observed response schemes. As a results the variation is 0 and we cannot compute
a correlation coeﬃcient. We resolve this by simulating a “(control) vs (stimulation+)”
contrast which concatenates a  1 to the ORS of every E-gene (figure 8.4). This is valid,
because all selected E-genes are diﬀerentially regulated between negative and positive
controls (stimulation).
We use Spearman’s rank correlation and size penalty  = 10 10 for the score (4.1)
and the BGNS for the optimization. We start from the empty network and the PKN
with identical results (figure 8.5). Our result is most similar to the one of Anchang et al.
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Figure 8.5: B-NEM compared to other NEM extensions. The transitive reductions
of the results from diﬀerent methods. (1) B-NEM with  =  1. (2) B-NEM with
 2 f0:8; 0:9g. This is in accordance to the estimation of Anchang et al. (2009). (3)
pNEM (Sadeh et al. (2013)). (4) Fast and eﬃcient dynamic nested eﬀects models
(Froehlich et al. (2011)).
(2009) except for the switch of Oct4 and Tcl1. However Anchang et al. (2009) employ a
null S-gene (Tresch & Markowetz (2008)) to exclude E-genes with a bad overall fit. Thus
we employ the automatic E-gene selection (4.5) and try diﬀerent values for . Values
lower than 0:8 do not exclude any E-genes. For  2 f0:8; 0:9g our new optimal network
is identical to the one of Anchang et al. (2009).
8.3.1 Resolving Dynamic Feedback
In this section, we learn the underlaying Boolean network structure from the eight time
points using algorithm 8. Following the last section, we set  to 0:8
The estimations for each separate time point are shown in figure 8.6. We resolve
similar individual time points as Wang et al. (2014). Tcl1 is always at the bottom of
the network, while Tbx3 is at the top in all eight time points. All other S-genes switch
positions. Nanog moves from almost at the bottom in the early time points to the very
top. In contrast Oct4 starts at the top and ends up downstream of all but Tcl1. Sox2
and Esrrb do not change their position much.
Figure 8.7, left shows the network estimated with algorithm 8. Tcl1 is concertedly
activated through an AND-gate by all other S-genes except Tbx3. However Tbx3 can
indirectly activate Tcl1 together with Oct4. Nanog is alternatively activated by Oct4 or
Tbx3. Only Sox2 can activate Oct4. Nanog or Oct4 alternatively activate Sox2. Tbx3 is
the only activator of Esrrb.
The most prominent subnetwork is the cycle consisting of Nanog, Sox2 and Oct4
(green). Wang et al. (2014) also identify this triple as the main feedback mechanism
in this pathway. Furthermore the String1 database shows Oct4, Nanog and Sox2 to be
highly connected as well.
1STRING, http://www.string-db.org/, Franceschini et al. (2013), figure 8.7, right
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Figure 8.7: B-NEM estimates a cyclic Boolean network from time series data.
Left: B-NEM estimation with algorithm 8. Right: String database interactions. POU5F1
and TCL1A=B are the HGNC genesymbols (Gray et al. (2015)) for Oct4 respectively
Tcl1.
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9Conclusion and Outlook
We introduce a novel method (B-NEM) to infer complex structures of protein signalling
pathways based on indirect eﬀects of perturbation experiments. B-NEM combines the
CellNet Optimizer of Saez-Rodriguez et al. (2009) with Nested eﬀect Models by Markowetz
et al. (2005, 2007). We employ the Boolean network modelling and prior knowledge in-
tegration of the CNO, but like NEM we infer the pathway topology based on indirect
transcriptional eﬀects instead of direct measurements of the proteins involved.
We validate B-NEM on simulated data and apply it to three diﬀerent cancer related
datasets. The first application to B Cell receptor signalling shows B-NEMs strength, if
the dataset includes combinatorial knock-downs. The double and triple knock-downs of
Ikk2, p38 and Jnk allow for reconstruction of the subnetwork.
In the application to Tnf- and Trail signalling we have only single knock-downs
at our disposal. However a double stimulation of Tnf- and Trail combined with the
integration of prior knowledge lets us estimate a Boolean network of the underlaying
pathway. For example we infer redundant signalling into NFB. Nemo mediates the
signal to the transcription factor RelA (NFB), but the signal to Nemo can only be
blocked by the receptors. Furthermore Trail needs the constitutively active WNT signal
(Beta-Catenin) to induce apoptosis (Casp8).
In the last application we apply B-NEM to time series data derived from mouse
embryonic stem cells. We show that we can use the information from each individual
time point to estimate a Boolean network without combinatorial knock-downs or prior
knowledge.
In the future, data production will become cheaper and predestined for combinatorial
perturbation experiments. However it has to be assured that experiments with multiple
simultaneous knock-downs and stimulations work as they are supposed to, because as with
single knock-downs there will be unwanted eﬀects. For example siRNA have significant
oﬀ-target eﬀects. The siRNA does not only deplete the target but also other mRNAs.
Pools of siRNA, several siRNAs targeting the same gene, can reduce these oﬀ-target
eﬀects (Jackson & Linsley (2010); Hannus Michael et al. (2013)). The assumptions is
that every siRNA has its own unique set of oﬀ-target eﬀects, while all have the same
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on-target eﬀect. Thus the oﬀ-target eﬀects will average out and the on-target eﬀect will
remain.
siRNA experiments result only in a knock-down of the target gene, since the de-
pletion of the mRNA by siRNA is only partial. Thus the gene and its corresponding
protein will still show some activity. However in a knock-out the gene is completely
removed and fully depletes the mRNA. Knock-outs are possible with the novel DNA
editing method CRISPER-Cas (CRISPER: clustered regularly interspaced short palin-
dromic repeats, Cas: CRISPER associated protein). CRISPER-Cas is used to edit the
genome and thus experimental biologists can cut out a whole gene (Beisel et al. (2014);
Li et al. (2014); Shalem et al. (2014)). The resulting knock-out data is more suitable
for B-NEM, because the Boolean formulation assumes discrete states such as active (1)
or inactive (0) as in a knock-out. However B-NEM also works on knock-down data, as
we have demonstrated.
Future experiments and designs will increase the power of B-NEM. However the
method is still very much extendable. Other static (Vaske et al. (2009); Zeller et al.
(2009); Niederberger et al. (2012)) and dynamic modelling approaches (Anchang et al.
(2009); Froehlich et al. (2011)) have already extended the original NEM. Alternatively
qualitative Boolean models as in B-NEM can be turned into a quantitative system of ordi-
nary diﬀerential equations (ODE, Wittmann et al. (2009); Henriques et al. (2015)). This
system can then be used to exploit more details in time series data. However ODEs are
generally more computational expansive and too few time points can lead to overfitting.
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APPENDIX A
Signal Propagation
In this chapter we discuss some additional topics regarding the signal flow in BGs and
introduce algorithms we use to tackle this problem. We start with the transitive closure of
a BG. Then we introduce an algorithms to calculate the activation states of the vertices.
Finally we use Boolean networks to model the rules of Rock, Paper, Scissors, Lizard,
Spock1. We also build a classifier to predict game outcomes.
A.1 Transitivity
Definition A.1 (Implied Boolean function). Let G = (V;H) be a Boolean directed hyper-
graph. A Boolean function f : f0; 1gn ! f0; 1g is implied by G, if there is a rooted tree
T  G (orientation towards the “root”) that corresponds to f : the sources (vertices without
parents) of T are the inputs of f and and the sink (root) is the output.
For example the hyper-graph 1 in figure A.1a implies the function C = :A^B, because
it has a corresponding hyper-edge and the function E = :C ^ D = :(:A ^ B) ^ D =
(A _ :B) ^D = (A ^D) _ (:B ^D), because it corresponds to a rooted tree.
Definition A.2 (Transitive closure of a BG). Let G = (V;H) be a Boolean directed
hyper-graph and G^ = (V; H^) a Boolean directed hyper-graph with the following properties:
1. H  H^
2. for every Boolean function f implied by G, there exists a set fh1; : : : ; hng  H^
which corresponds to f .
G^ is the transitive closure of G.
This definition of transitive closure is in conformity with the special case of the original
Nested Eﬀects Models (Markowetz et al. (2005, 2007); Tresch & Markowetz (2008)). For
1Sam Kass, Karen Bryla, http://www.samkass.com/theories/RPSSL.html
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example consider the graph G = fA! B ! Cg. We can write C = B = A. G implies
C = A. Thus the transitive closure is G^ = G [ fA! Cg.
In the context of B-NEM a Boolean hyper-graph is not necessarily equivalent to its
transitive closure. If two vertices are only indirectly connected with each other, the
knock-in or knock-down of intermediate vertices makes them independent. For instance
if we knock-down the intermediate B in the previous example, we have CjG = BjG = 0
and CjG^ = AjG^ _ BjG^ = AjG^ _ 0 = AjG^. Therefore the graphs are not equivalent for
the knock-down of B, [G] 6=
h
G^
i
. Nevertheless, the transitive closure is still a good way
to asses signalling properties, given no perturbation of the intermediate vertices. Thus
we outline an algorithm (9) to construct the transitive closure or an approximation for a
given BG.
Algorithm 9 transitive closure of a Boolean hyper-graph
1. input Boolean hyper-graph G = (V;H)
2. iterate over n steps (n = jV j  2 is suﬃcient, but not minimal for the full transitive
closure)
(a) iterate over edges h^ (W; c) 2 H
i. iterate over vertices w 2 fw : w 2 W;9h = (U;w) 2 Hg
A. replace w in the AND-clause corresponding to h^ with the DNF corre-
sponding to the hyper-edges h with w as child
B. convert newly formed normal form c to a DNF
C. add the hyper-edges corresponding to the AND-clauses of c to the
the graph G
(b) if no novel edges were added during the current iteration: break
Small values for the step parameter n lead to an approximation of the full transitive
closure. An example for a BG and its transitive closure is shown in figure A.1a. Basically,
what the algorithm does, it replaces the literals in the original DNF of the vertex with
other DNF(s) of its parents and uses Boolean algebra to transform the normal form back
to a DNF, if necessary. For instance in figure A.1a we compute
E = :C ^D = : (:A ^B) ^D = (A _ :B) ^D = (A ^D) _ (:B ^D)
F = :C = : (:A ^B) = A _ :B: (A.1)
Figure A.1a, 2 shows the corresponding hyper-edges in the transitive closure. The result
can be complex. For example in figure A.1c we add the corresponding hyper-edges to the
following DNFs:
E = :C ^D = :A ^D
E = :C ^D = :C ^B
E = :C ^D = :A ^B: (A.2)
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stays, since A = 1 does not
indirectly cause E = 1.
Figure A.1: Examples for transitivity. Examples for the transitive closure (a-d) and
the reduction (e) of BGs.
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For large graphs the transitive closure can be too complex for an investigation by eye.
Therefore it is helpful to look at only a subset of the graph. For example in figure A.1b, we
look at the sub-graph including all edges with vertex A in the parent set. This reduction
lets us examine the (in)-direct influence of A on all other vertices of the network. Given
C = 0, A positively regulates D and given G = 0 or H = 1, A negatively regulates F.
Furthermore, the absorption law can also help to make the transitive closure less complex
without loosing information (figure A.1d).
Similarly to the closure, we can compute the transitive reduction of a BG. Basically,
we remove all feed forward loops of the original graph G and calculate its transitive
closure G^. G is G without any feed forward loops. Only feed forward loops in G, which
are not explained by G^ are kept and the rest removed (figure A.1e, algorithm 10).
Algorithm 10 transitive reduction of a Boolean hyper-graph
1. input Boolean hyper-graph G
2. make a copy G of G
3. remove all feed forward loops in G
4. calculate the transitive closure G^ of G
5. remove all feed forward loops in G which are also in G^
A.2 Simulated signal propagation
Given a boolean network 	 B-NEM compares simulated states of S-gene with measure-
ments of E-genes. Before we can calculate the similarity between E-genes and S-genes,
we need to simulate the S-gene states for a given network and conditions. A condition C
defines a subset I  V of vertices we set to 0 or 1 independently of their parents. Vertices
not in I have an unknown initial state. This state is calculated based on the states of
the vertices in I. We accomplish this by a recursive implementation of the algorithm 11.
It is a generalization of depth first search (Tarjan (1972); Wilson (1996)) to BGs.
Algorithm 11 signal propagation
1. start with a random, S-gene S which has unknown states
2. calculate the parent set pa(S)
3. if all parents have states 0; 1 for all experimental conditions, calculate the states of
S for all experiments and proceed with step 1
4. if a parent has not been assigned states 0; 1 over all experimental conditions, proceed
with this parent as the new S in step 2
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Figure A.2: State calculation in a DAG. We resolve the DAG in steps 1-7. Blue
vertices have been assigned states 0 or 1. Vertices with a red border are currently under
investigation. The starting vertex Z has parents X and Y which in turn have parents U,V
and W. They are top vertices without parents and are initiated with 1 or 0. After the
initiation of U, V and W, the states of X, Y and subsequently Z are calculated.
This algorithm can only process DAGs (figure A.2). In the next section we present
an adjusted algorithm for graphs including cycles.
Cycles
Sometimes we have to deal with BGs that include cycles. For example if we are not sure
whether S-gene A is upstream of B or B is upstream of A,
i.e. A ? ! B;
we have to include cycles in the PKN (e.g. figure 6.1). However it is easy to see that
every sub network of an extended PKN without negative edges has a well defined ERS.
In contrast a PKN with negative edges can lead to an undefined ERS (figure A.5).
If we have a standard set of experiments (definition 4.4), every normal graph without
hyper-edges, but with a cycle is equivalent to a DAG (figure A.3 and Zeller et al. (2009)).
However a more complex set of experiments resolves this equivalence (figure A.4). If the
PKN contains cycles and negative regulation, there are cases in which the network does
not define an ERS (figure A.5). During the control experiment the stimulation S0 is 0.
This leads to the following oscillation of states:
(S1 = 0)) (S2 = 0)) (S3 = 0)) (S4 = :S3 = 1)) (S1 = 1)) (S2 = 1)
) (S3 = 1)) (S4 = 0)) (S1 = 0): (A.3)
The activation states are well defined for all other experiments.
The following algorithms detect cycles using depth first search (figure A.6, Tarjan
(1972)) and assign the correct states to all vertices in a positive Network (A.7, 1-2).
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Figure A.3: Equivalence of DAGs and graphs with cycles. Example for two equiv-
alent networks given standard experiments. The left network contains a cycle, the right
is a DAG. The DAG is preferred due to its smaller size.
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Figure A.4: Special experiments to resolve cycles. The same networks as in fig-
ure A.3, but with a diﬀerent set of experiments. The two ERSs clearly diﬀer and the
networks are not equivalent.
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S0 S1 S2 S3 S4
Figure A.5: Negative cycles lead to oscillation. Network with a cycle including
a negative edge and its activation states. Black is active during the experiment, white
inactive and grey undefined (=oscillating). We cannot resolve the states of S-genes S1 S4
in the control experiment (S0 = 0).
Algorithm 12 cycle detection
1. start with a random S-gene S and empty set C for children/descendents
2. calculate the parent set pa(S) and put S in C
3. if there exists a S 2 pa(S) with S 2 C, a cycle is detected, if not proceed with
step 2 and replace S with the parents S 2 pa(S)
Algorithm 13 resolve cycle
1. cycle detected between parent A and child B
2. temporarily set B = 0
3. calculate A
4. unset B
5. calculate B
In the example of figure A.7, 1 we start with W .
W = A = S _ :B = S _ ::V = S _ V = S _W:
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Figure A.6: Example for cycle detection. We resolve the cycle in steps 1-8. Let’s
assume the algorithm starts at vertex Z. The parents are recursively investigated via Y,X
and W until vertex T. T is assigned its state (blue). V, the second parent of W, leads
to U. U has Y as a parent, but Y has already been a “grand”-child of U and therefore a
cycle has been detected (green).
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S1
S2
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A
B
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W
Figure A.7: Graphs with diﬀerent kinds of cycles. Examples of graphs with positive
cycles (1, 2), which our signal propagation algorithm can handle. The graph with the
negative cycle (3) produces oscillating states for each vertex in the cycle and we cannot
resolve a real steady state.
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Next we set V = 0 and calculate W .
W = S _ V = S _ 0 = S:
Now we unset and calculate V .
In the second example (figure A.7, 2) we calculate
A = S1 _B = S _ S2 _ A = S _ A:
We set B = 0 and calculate
A = S1 _ 0 = S;B = A _ S2 = S:
Negative cycles are more complicated, because they can lead to oscillating states.
Figure A.7, 3 shows an example. A is defined by its own negation.
A = S _ :B = S _ :V = S _ :W = S _ :A:
We can detect the cycle and use the algorithm to calculate a steady state, if possible,
and a pseudo steady state otherwise. In a pseudo steady state we randomly initiate one
vertice of the oscillating cycle with 0 or 1 and compute the remaining unknown states.
Fortunately conditions with perturbations lead to few pseudo steady states (figure A.5),
because a perturbed vertice is independent of the hyper-graph. For example if a vertice
X in the cycle is initiated with a 0 (knock-down) or 1 (knock-in), the states of all vertices
in the cycle are well defined and there is no oscillation, because X always remains in its
initiated state.
A.3 Diﬀerent Problem - same Method
Several diﬀerent problems in science have the same abstracted mathematical formula-
tion. Hence the same method for one problem can be applied to a diﬀerent problem.
For example Ross & Markowetz (2016) transfer the concept of NEM from pathways to
oncogenetic trees inferred from single cell data (oncoNEM). Oncogenetic trees model the
tumor evolution in specific cancer tissues. The root of the tree is usually the unmutated
cell population followed by clones with increasing numbers of mutations. Basically Ross
& Markowetz (2016) replace S-genes with clone types, E-genes with single cells and eﬀects
with mutations. Thus if clone B evolved from clone A (A ! B), the number of single
cells with mutations of type clone B are a noisy subset of single cells with mutations of
type clone A.
Conceptually similar to Ross & Markowetz (2016), we use Boolean networks often
used for inference and prediction in biology (Saez-Rodriguez et al. (2009, 2011); Pirkl
et al. (2016)) and use them to model the game Rock, Paper, Scissors. Additionally we
use Boolean networks as an alternative to established classification methods.
Rock, Paper, Scissors
Rock, Paper, Scissors is a game used to break a gridlocked argument between two people
(Wikipedia (2015)). They both count to three and simultaneously make one of three
specific signs:
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• Rock = fist
• Paper = all fingers extended and held together
• Scissors = index finger and middle finger extended and held apart
The rules are
• Rock crushes Scissors
• Paper covers Rock
• Scissors cuts Paper
For example if person A shows Rock and person B shows Scissors, person A wins (Rock =
1) and B loses (Scissors = 0). We model those rules as a Boolean network. The literals
are V = fRock; Paper; Scissorsg and the corresponding Boolean network is
	 = (Rock = :Paper; Paper = :Scissors; Scissors = :Rock) :
The sign(s) not used by the two players are set to 0. We introduce the convention, if
both players show the same sign, both win.
Rock, Paper, Scissors, Lizard, Spock
Rock, Paper, Scissors, Lizard, Spock (RPSLS, figure A.8, left) is an extension to the
original game to lower the probability of a tie. RPSLS introduces additional rules:
• Rock crushes Lizard (hand formed to “sock”-puppet)
• Paper disproves Spock (the vulcan salute2)
• Scissors decapitates Lizard
• Lizard eats Paper and poisons Spock
• Spock smashes Scissors and vaporizes Rock
If player A shows Rock and player B shows Paper, the literals set to 0 are
I = fScissors; Lizard; Spockg :
The vertices Rock and Paper have to be resolved by signal propagation given a Boolean
network. The rules dictate Rock = 0 and Paper = 1.
We can simulate a dataset given the above rules. The datamatrix D = (dij 2 f0; 1g)
with all possible game combinations consists of
5
3

+

5
4

= 15
2Wikipedia (2016b)
100
Lizard
Paper
Rock
Scissors
Spock
AND
AND
AND
AND
AND
Figure A.8: Rock, paper, scissors, lizard, Spock. Left: A graphical representation of
Rock, Paper, Scissors, Lizard, Spock (Wikipedia (2015)). An edge denotes the winning
sign (parent) and loosing sign (child). Right: The Boolean hyper-graph denoting the
rules.
unique3 game outcomes (columns) for 5 literals (rows). We do not use any prior network,
but the complete set of possible hyper-edges. We resolve the underlaying Boolean network
with the CNO (Saez-Rodriguez et al. (2009)), the BGNS (algorithm 7 with starts: empty
network, PKN) and adjusted state simulation algorithms (11-13) to resolve the Boolean
network (figure A.8, right, equation (A.4)).
	 =(Rock = :Paper ^ :Spock; Paper = :Scissors ^ :Lizard;
Scissors = :Rock ^ :Spock; Lizard = :Rock ^ :Scissors;
Spock = :Paper ^ :Lizard) :
(A.4)
Supervised learning with Boolean networks
We use 50% of the random unique experiments (training set) and learn a network as
before. We then use this network to predict the outcome of the games (experiments)
not used for learning (test set). We compare our method with the R implementations of
support vector machines (SVM, Meyer et al. (2014)), neural networks (NN, Venables &
Ripley (2002)) and self organizing maps (SOM, Wehrens & Buydens (2007)) with default
parameters.
The results of 1000 runs are shown in figure A.9. Even though the correct network
is hard to learn from incomplete data, the sensitivity and specificity of the predicted
winners are high. Specificity is almost equal for all four methods. However Boolean
networks reach the highest sensitivity.
3Quadruple inhibitions (if both players show the same sign) and triple inhibitions (if both players
show diﬀerent signs) of the five vertices.
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Figure A.9: Prediction sensitivity and specificity. Boxplots of sensitivity and speci-
ficity for the predicted hyper-edges (only Boolean networks) and the predicted winner(s)
for 1000 runs.
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APPENDIX B
Similarity Measures
In this section we review several similarity measures which can be used for A in the score
of B-NEM (equations (4.1),(4.5)).
Cosine similarity
Cosine similarity (Singhal (2001); Sidorov et al. (2014)) for two vectors X;Y 2 Rn with
X = (x1; : : : ; xn) and Y = (y1; : : : ; yn) uses the euclidean dot product
< X; Y >=
nX
i=1
xi  yi
and norm
k:k =
p
< X;X >:
It is defined as
C (X; Y ) = hX; Y ikXk  kY k 2 [ 1; 1] (Schwarz inequality, Lang (2000))
C(X; Y ) is the cosine of the angle  between vectors X and Y in the two dimensional
euclidean space R2. The smaller , the more similar are X and Y . An angle of 180
degrees corresponds to a cosine similarity of  1 and one of 0 degrees to 1. C is scale, but
not shift invariant.
Correlation
Correlation (Kendall (1938); Fahrmeir et al. (2007)) is a general measure of association,
which can be interpreted as a similarity measure.
103
Pearson’s r
Pearson’s correlation for two variables X and Y is defined as
Cor (X; Y ) =
Cov (X;Y )p
Var (X)Var (Y )
=
E (X  Y )  E (X)  E (Y )q 
E (X2)  E (X)2  E (Y 2)  E (Y )2
with first moment E, variance Var and covariance Cov. If we rewrite the correlation with
the sample moment X we have
Cov (X;Y ) = 1
n


X  X;Y   Y  :
and analogously
Var (X) =
1
n


X  X;X  X = 1
n
X  X2 :
Thus it follows for Pearson’s sample correlation
rXY = C
 
X  X; Y   Y  :
Pearson’s correlation is therefore not only scale, but also shift invariant. Any shift is
subtracted with the mean.
Spearman’s 
If a nonlinear relationship between X and Y is assumed, we can use Spearman’s rank
correlation .
XY = rrank(X) rank(Y ) = C

rank (X)  rank (X); rank (Y )  rank (Y )

:
It has to be taken into consideration, that ranking the ORS for every E-gene takes
more time. Fortunately the ORS has to be ranked only once before the optimization.
Additionally the length of the intervals between subsequent values f1; 0; 1g in the ERS
is constant 1. Thus ranking the ERS is just a shift and scale operation (average ranks,
Fahrmeir et al. (2007)). However Pearson’s r is shift and scale invariant. Therefore we do
not need to rank the ERS at all. This fact makes Spearman rank correlation practically
as fast as Pearson’s in the case of B-NEM.
Kendall’s 
For the sake of completeness we have a look at Kendall’s rank correlation  . Even
though it takes more time to compute than the others, it might hold some interesting
properties such as faster convergence for increasing sample sizes and higher mathematical
tractability (Gilpin (1993)).
For the two sample vectors X = (xi)i21;:::;n ; Y = (yi)i21;:::;n all pairs i; j are examined
for concordance. A pair i; j is concordant, if xi < xj and yi < yj or xi > xj and yi > yj.
A pair is discordant, if xi < xj and yi > yj or xi > xj and yi < yj. A pair i; j is neither,
if xi = xj or yi = yj. Kendall’s rank correlation is defined as
XY =
(number of concordant pairs) (number of discordant pairs)
1
2
n(n 1) :
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Distance
Given two vectors s; e 2 Rl of the S-gene respectively E-gene, a distance measure is an
intuitive way to assign a similarity score. For example the euclidean distance is defined
as
De (s; e) = ks  ek :
However we must consider, that the E-gene data needs to be normalized or discretized
beforehand or we get obscure results. For example the euclidean distance between
Si = (1; 0; 0; 0) and Ej = (7:1; 0:2; 0:1; 0:3) is greater than between Si and Ek =
(0:4; 0:2; 0:1; 0:3) (equation (B.1)), but Ej is clearly the better “fitting” E-gene. Its
eﬀects are just not scaled to [ 1; 1].
De (Si; Ej)  6:1 > 0:7  De (Si; Ek) : (B.1)
The implementation in the R package “flexclust” (R Core Team (2014); Leisch (2006))
allows for a fast computation. Additionally “flexclust” includes several other distance
measures besides euclidean.
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APPENDIX C
Normalization to [0; 1]
In our B-NEM approach in chapter 4 our input ORS foldchanges from diﬀerential gene
expression. As an alternative to foldchanges we can normalize the raw expression values
to [0; 1] and use the mean squared error from Saez-Rodriguez et al. (2009). We achieve
this normalization with a method similar to Curry (2013). The method is based on the
assumption that a gene, relevant in the context of the experiments, has basically two
states 0 and 1. So most of its values are eﬀectively either 0 or 1 or are at least close to
them. We assume a small transition phase (0 << x << 1) of just a few values further
away from both 0 or 1.
Algorithm 14 and equation (C.1) show the details of the normalization. In short we
start with a 2-means clustering (MacQueen (1967)) of the log2 normalized expression
values of a gene over all samples. Then we normalize the silhouette scores (Rousseeuw
(1987)) to [0; 1].
xnormi =
( 1)ci 1S(xi) min
j
f( 1)cj 1S(xj)g
max
j
n
( 1)cj 1S(xj) min
k
f( 1)ck 1S(xk)g
o : (C.1)
ci 2 f1; 2g denotes the cluster of xi and S(xi) the silhouette score of xi given the 2-means
clustering c = (ci). We assume without restriction, that the values in cluster two are the
low values and in cluster one the high values. Figure C.1 visualizes the transformation
on a toy gene.
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Algorithm 14 normalization to [0; 1]
1. 2-means clustering of gene expression values
2. replace values with silhouette scores
3. multiply values from cluster two with  1
4. subtract minimum value from all values
5. divide all values by the maximum value
ll
l
lll
ll
lll
ll
lll
lll
lllllll
ll
llllll
llll
ll
lll
lllllll
lllll
lllllll
llllll
llll
lll
llllll
ll
llll
lll
ll
l
llll
l
l
l
0 20 40 60 80 100
−
2
−
1
0
1
2
rank
ex
pr
es
sio
n
l
ll
l
l
ll
l
lll
l
ll
ll
l
ll
lll
lll
lll
lllll
ll
lllll
l
lllllll
lll
llllll
llll
llllllllll
lllllllll
lllllllllll
lllllllll
0 20 40 60 80 100
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
0.
7
rank
si
lh
ou
et
te
 s
co
re
lllllllllll
llllll
llllll
ll
l
llllll
l
l
ll
l
l
l
l
l
l
l
ll
lll
ll
ll
lllll
lll
lllll
lllll
llllll
llllllllllll
llllllllllll
0 20 40 60 80 100
−
0.
6
−
0.
4
−
0.
2
0.
0
0.
2
0.
4
0.
6
rank
si
lh
ou
et
te
 s
co
re
 w
ith
 in
ve
rs
e
 s
e
co
n
d 
clu
st
er
lllllllllll
llllll
llllll
ll
l
llllll
l
l
ll
l
l
l
l
l
l
l
ll
lll
ll
ll
lllll
lll
lllll
lllll
llllll
llllllllllll
llllllllllll
0 20 40 60 80 100
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
rank
n
o
rm
a
liz
e
d 
sil
ho
ue
tte
 s
co
re
 w
ith
 in
ve
rs
e
 s
e
co
n
d 
clu
st
er
Figure C.1: [0; 1]-normalization. Toy example. Normalization of the expression values
to [0; 1] in three steps. The raw data (top-left), silhouette scores (top-right), silhouette
scores of cluster two inverted (bottom-left) and scaled to [0; 1] (bottom-right).
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APPENDIX D
Supplementary Figures
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Figure D.1: Simulation results. Same as in figure 5.2 except with continuous noise
 2 f0:5; 1; 2g.
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Figure D.2: Positive cyclic PKN. Example of a randomly created Super-PKN with 30
nodes and 144 edges in a normal cyclic graph. S1 to S6 are nodes which can be set to 0
or 1 as possible stimulations. A node denoted with I can be inhibited and if not is set by
the states of its parents. Each edge has a 10% chance of being reversed. Extending this
PKN with AND gates of size 2 leads to a hyper-graph with roughly 500 hyper-edges.
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Figure D.3: General cyclic PKN.Example of a randomly created Super-PKN with 30
nodes and 144 edges in a normal cyclic graph. S1 to S6 are nodes which can be set to 0
or 1 as possible stimulations. A node denoted with I can be inhibited and if not is set
by the states of its parents. Each edge has a 10% chance of being reversed and another
10% chance of being negative. Extending this PKN with AND gates of size 2 leads to a
hyper-graph with roughly 500 hyper-edges.
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Figure D.4: Simulation results for cyclic prior. Same as in figure 5.2 except we used
the cyclic PKN (figure D.2) instead of the DAG (figure 5.1).
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Figure D.5: Simulation results for cyclic prior with negation. Same as in figure D.4
except we allowed negative edges in the cyclic PKN (figure D.3).
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Figure D.6: Simulation results for cyclic prior. Same as in figure D.4 except with
continuous noise  2 f0:5; 1; 2g.
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Figure D.7: Simulation results for cyclic prior with negation. Same as in figure D.5
except with continuous noise  2 f0:5; 1; 2g.
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Figure D.8: Core TNF--TRAIL-WNT PKN. Interpretation of the KEGG
pathway database as a directed normal graph (Kanehisa & Goto (2000); Kane-
hisa et al. (2014), http://www.genome.jp/kegg-bin/show_pathway?hsa04668,
http://www.genome.jp/kegg-bin/show_pathway?ko04010+K04450,
http://www.genome.jp/kegg-bin/show_pathway?hsa04210,
http://www.genome.jp/kegg-bin/show_pathway?hsa04310).
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Figure D.9: Updated PKN. Modified PKN to account for systematic/strong residuals
in figure 7.5. Blue edges with a diamond head denote ambiguous regulation (! and a
possible).
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Figure D.10: Remaining residuals in the Data. Residuals in the observed response
scheme for the improved network in figure 7.7.
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Figure D.11: Top Casp8 regulated E-genes for the updated result. The bottom
row is the expected response scheme of Casp8. The other rows show the observed response
schemes of attached E-genes.
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Figure D.12: Top Tcf4 regulated E-genes for the updated result. The bottom
row is the expected response scheme of Tcf4. The other rows show the observed response
schemes of attached E-genes.
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The following list contains often used abbreviations for quick reference.
B-NEM . . . . . . . . . . . Boolean Nested Eﬀects Models
BAG. . . . . . . . . . . . . . Boolean directed acyclic hyper-graph
BCR. . . . . . . . . . . . . . B-Cell receptor
BG . . . . . . . . . . . . . . . Boolean directed hyper-graph
BGNS . . . . . . . . . . . . Boolean greedy neighbourhood search
BN . . . . . . . . . . . . . . . Bayesian network
CNF. . . . . . . . . . . . . . conjunctive normal form
CNO . . . . . . . . . . . . . CellNet Optimizer
D-NEM. . . . . . . . . . . Dynamic Nested Eﬀects Models
DAG . . . . . . . . . . . . . directed acyclic graph
DNA . . . . . . . . . . . . . deoxyribonucleic acid
DNF. . . . . . . . . . . . . . disjunctive normal form
ERS . . . . . . . . . . . . . . expected response scheme
FDR. . . . . . . . . . . . . . false discovery rate
FG-NEM . . . . . . . . . Factor Graph Nested Eﬀects Models
GA . . . . . . . . . . . . . . . genetic algorithm
GGM . . . . . . . . . . . . . Gaussian graphical models
GNS . . . . . . . . . . . . . . greedy neighbourhood search
GTN . . . . . . . . . . . . . ground truth network
HCC. . . . . . . . . . . . . . hepatocellular carcinoma
KEGG. . . . . . . . . . . . Kyoto Encyclopedia of Genes and Genomes
MAD . . . . . . . . . . . . model adaptive discretization (score)
mRNA. . . . . . . . . . . . messenger RNA
NEM . . . . . . . . . . . . . Nested Eﬀects Models
NN . . . . . . . . . . . . . . . neural nets
NRM . . . . . . . . . . . . . negative residuals matrix
oncoNEM. . . . . . . . . oncogenetic Nested Eﬀects Models
ORS . . . . . . . . . . . . . . observed response scheme
P-NEM . . . . . . . . . . . Partial Nested Eﬀects Models
PDAG . . . . . . . . . . . . partially directed acyclic graph
PKN. . . . . . . . . . . . . . prior knowledge network
PRM . . . . . . . . . . . . . positive residuals matrix
Rluc . . . . . . . . . . . . . . Renilla luciferase
RNA . . . . . . . . . . . . . ribonucleic acid
shRNA . . . . . . . . . . . short hairpin RNA
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siRNA . . . . . . . . . . . . small interfering RNA
SOM . . . . . . . . . . . . . self organizing maps
SUS . . . . . . . . . . . . . . stochastic universal sampling
SVM. . . . . . . . . . . . . . support vector machines
Tnf- . . . . . . . . . . . . Tumor necrosis factor 
Trail . . . . . . . . . . . . . . TNF related apoptosis-inducing ligand
UTS . . . . . . . . . . . . . . unbiased tournament selection
WNT . . . . . . . . . . . . . Wingless-Type
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